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ABSTRACT 
 
INVESTIGATING THE IMPACT OF SMALL MOLECULES LIGANDS AND THE 
PROTEOSTASIS NETOWRK ON PROTEIN FOLDING INSIDE THE CELL 
 
SEPTEMBER 2016 
 
KARAN S. HINGORANI  
B.Sc., ST. XAVIER’S COLLEGE, UNIVERSITY OF MUMBAI 
 
PhD., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Lila M. Gierasch 
 
 
The folded forms of most proteins are critical to their functions. Despite the complexity 
of the cellular milieu and the presence of high-risk deleterious interactions, there is a high 
level of fidelity observed in the folding process for entire proteomes. Two important 
reasons for this are the presence of the quality control machinery consisting of 
chaperones and degradation enzymes that work jointly to optimize the population of the 
folded state and interaction partners that re-enforce the functional state and add to the 
competitive advantage of an organism. While substantial effort has been directed to 
understand protein folding and interactions in vitro, comparatively little of these 
processes are explored inside the cell. This work examines two important aspects of 
protein folding inside the cell; first, the impact of small molecule ligands on protein 
folding; and second, the impact of the proteostasis network on the folding of an 
obligatory chaperone client. We deploy a combination of experiments and mathematical 
modeling based on the principle of kinetic partitioning to understand how these 
		viii 
phenomena sculpt the protein folding landscape inside the cell. We find that ligands 
specifically deplete unfolded and aggregation- or degradation - prone protein populations 
by favoring the folded state and the chaperone and degradation proteins work to 
minimize off-pathway species thus reducing the population of aggregated protein inside 
the cell.  
		 ix 
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CHAPTER 1 
INTRODUCTION 
 
Proteins are essential biomolecules that execute vital cellular functions. For most proteins 
to function correctly, they must fold into their correct three-dimensional shape and 
interact appropriately with their partners. While much is known about protein folding in 
in vitro systems, there remains much work to be done to understand how protein folding 
occurs with fidelity inside the cell. In this chapter I will discuss some current progress on 
the 1) status of protein folding research in vitro, 2) how protein folding inside the cell can 
be vastly different from folding inside the test tube and the factors that can contribute to 
protein folding in vivo, 3) the concept of kinetic partitioning which can be used to 
understand how the differences in vitro and in vivo manifest in the folding reaction and 
finally 4) the questions that I have tried to address during the course of my thesis which 
are directed at understanding certain aspects of the cellular environment that influence 
protein folding. Sections of this chapter were co-authored with my advisor and published 
in the review “Comparing protein folding in vitro and in vivo: Foldability meets the 
fitness challenge” Current Opinion in Structural Biology February 2014. 
 
1.1. Protein folding in vitro: 
In the sixty-odd years since Anfinsen’s pioneering work showing the ability of RNaseA 
to re-fold from a reductively denatured state (Anfinsen, 1973), the mechanism of protein 
folding and how amino acid sequence encodes a folding reaction have been extensively 
studied (Daggett and Fersht, 2003; Dill et al., 2008). Increasingly powerful experimental 
		 2 
and computational methods have been focused on the intellectually seductive in vitro 
‘protein folding problem’, defined to be the relationship between amino acid sequence 
and the adoption of a native fold. As a consequence, we know a great deal about protein 
folding, but our knowledge is largely confined to how a protein folds at high dilution in 
conditions that are optimized for folding success.  
 
Small fast-folding domains have been the subject of extensive in-depth study in vitro 
because they are amenable to detailed physico-chemical analysis. For multiple reasons, it 
might be anticipated that the intrinsic folding behavior of these domains will solely 
determine their in-vivo folding properties. They fold on time scales (Daggett and Fersht, 
2003; Hingorani and Gierasch, 2014; Zhang and Ignatova, 2011) that are much faster 
(e.g., microseconds to milliseconds) than co-translational events (rate of synthesis in 
eukaryotes 5 amino acids/sec, or 15 amino acids/sec in E. coli). Also, they generally do 
not populate long-lived intermediates and do not present extensive hydrophobic 
surfaces—both necessary for binding interactions with chaperones. If such domains 
retain their intrinsic properties and their properties are not dominated by context, they 
may be viewed as the “atomic particles” of well-folded proteins in the cell. This view 
would allow researchers to treat large proteins as composites of smaller domains and, if 
parsed into even smaller units, ‘foldons’ (Maity et al., 2005). Thus, the insights on 
folding of small domains provided by ever more powerful experimental methods and 
impressive new computational capabilities may be applicable to explaining folding in 
vivo. For example, the description of transition path times using single-molecule Förster 
resonance energy transfer (FRET) sheds light on timescales of fundamental folding 
		 3 
events, and the promising simulations of folding at realistic timescales have afforded the 
opportunity to compare experiment and theory directly (Chung et al., 2012; Lindorff-
Larsen et al., 2011; Piana et al., 2013). Analysis of the folding trajectories computed by 
Anton, the supercomputer designed for protein folding simulations, offered a unifying 
mechanism for a dozen proteins and suggested that native-like contacts are formed in the 
unfolded state, with successive stabilization of key contacts driving the folding reaction. 
Progress in the simulation of folding reactions has also been reported by the Pande group, 
who showed that Markov state modeling and molecular dynamics (MD) simulations, 
accessible without Anton, generate kinetically relevant folding trajectories (Pande et al., 
2010). These researchers found evidence of glass-like kinetics using Markov state 
modeling of folding (Weber et al., 2013). Computational studies such as these may 
provide a possible bridge from theory to experiment. 
 
However, small single domain proteins are quite rare; for example, they represent less 
than 15% of the E. coli proteome (Braselmann et al., 2013). Moreover, recent work from 
several groups suggests that, even though large proteins can generally be broken down 
into smaller units by domain dissection, the folding of these component domains may not 
be independent, and thus what is seen for free-standing small-domain proteins may not be 
applicable to the universe of larger proteins in the proteomes of all organisms. 
Specifically, the domains of repeat proteins have been found to display context-
dependent folding (Sawyer et al., 2013; Vieux and Barrick, 2011). In addition, the 
coupling of domains of large proteins is often a key part of the function of the large 
protein (Ferreiro et al., 2011).  
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Thus it will be necessary to push the envelope of in vitro approaches and tackle larger 
proteins to understand a the folding mechanisms of a greater population of several 
proteomes. Some recent research has taken on this challenge, and results show how new 
complexities in folding landscapes will emerge when larger proteins are examined: Pirchi 
et al. deployed single molecule FRET coupled to hidden Markov analysis to uncover six 
metastable states and multiple folding routes along the folding landscape of adenylate 
kinase, a three-domain 23.5 kDa protein (Pirchi et al., 2011). The Rief laboratory used 
optical tweezer pulling experiments and hidden Markov analysis to study the folding of 
calmodulin and observed four on-pathway intermediates along with two off-pathway 
intermediates that compete with the productive folding reaction(Stigler et al., 2011). 
Dahiya and Chaudhuri (Dahiya and Chaudhuri, 2013) examined the folding of the 82 kDa 
multi-domain protein, malate synthase G, and concluded that weak interdomain 
cooperativity may add complexity to a folding pathway, including the possibility of a 
functional intermediate.  
 
Another research topic in in vitro folding that has seen impressive progress recently is the 
nature of the denatured or unfolded state ensemble and under what conditions this 
ensemble collapses.(Haran, 2012; Meng et al., 2013a; Meng et al., 2013b) A contentious 
point has emerged regarding how collapsed the unfolded state ensemble is under differing 
denaturant concentrations, and it now seems that the apparent results depend on the 
method of observation (Yoo et al., 2012). In any case, it remains unclear whether and 
when a polypeptide freely explores the unfolded state in vivo, apart from intrinsically 
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disordered proteins. Domains may transiently unfold or populate non-native states as they 
interact with chaperones (see below), and molecular machines that facilitate either 
translocation across membranes or degradation likely actively unfold proteins (Baker and 
Sauer, 2012; Tomkiewicz et al., 2007). Thus, the connections between non-native, 
unfolded states in vitro and in vivo should continue to be explored. 
 
1.2. Protein folding in vivo – what’s different? 
Proteins initially fold in vivo upon their biosynthesis. Hence, the first environment they 
are subjected to is created by the ribosome and ribosomally associated chaperone proteins 
and enzymes. In addition, chains may fold co-translationally before the entire chain has 
been made. In contrast, folding of proteins in vitro initiates from an unfolded ensemble in 
which a population of full-length chains (or in the case of single molecule experiments, 
one polypeptide) is subjected to folding conditions. Thus, the possibility of co-
translational folding constitutes a major difference between the de novo folding reaction 
in the test tube and in almost all cells of living organisms.  
 
Second, in vitro proteins sample their unfolded state in a dynamic equilibrium governed 
by their thermodynamic stability. Whether proteins spend much time unfolded in vivo is 
unclear. Many factors may disfavor accumulation of any significant population in the 
unfolded state, including chaperone binding, ongoing degradation, and kinetic barriers. 
Nonetheless, there may be lessons to be drawn from in vitro studies of unfolded states. 
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Third, protein-folding experiments in vitro are done at high dilution. In vivo, 
macromolecule concentrations range from 200 to 400 mg/ml, and highly interactive 
surfaces are present all around a folding chain are highly interactive. Thus, the impact of 
crowding and the influence of protein-protein interactions, including weak “Quinary” 
interactions (McConkey, 1982), must be taken into account (Figure 1.1). 
 
 
 
Figure 1.1 Cartoon representation of the complexity found in an E. coli cell where 
protein folding occurs 
  
The figure depcits computational modeling by McGuffee and Elcock to capture the 
crowded and heterogeneous environment of the E. coli cytoplasm. The modeling was 
performed with 50 of the most abundant proteins in E. coli at atomistic detail (Plos comp 
boil). Crowding in E. coli represents the high density of macromolecules and co-solutes 
(discussed in the macromolecular crowding section in this chapter) that have co-evolved 
with each other over the evolutionary time course. The high concentration of 
macromolecules necessarily forces weak and transient interactions between them giving 
rise to the term Quinary structure or if occurring in metabolic pathways – metabolons.  
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Fourth, while proteins fold on their own in vitro, a significant fraction have ‘helpers’ in 
vivo: molecular chaperones (Kim et al., 2013). It remains unclear to what extent and how 
chaperones alter the fundamental folding energy landscapes of proteins (Figure 1.2). 
 
Figure 1.2 Major components of the folding and degradation branches of the 
proteostasis network in E. coli 
 
A – GroEL (orange) and GroES (blue) (PDB 1aon) is homotetradecameric chaperonin of 
the Hsp 60 family of chaperones. It is posited to act as a conduit for folding by providing 
an environment for the unfolded polypeptide to fold without aberrant interactions with 
other molecules inside the cell. The complete activity of GroEL occurs in the presence of 
its co-chaperone GroES, which belongs to the Hsp 10 family of chaperones. 
 
 B- DnaK (purple – PDB 2kho) J domain of DnaJ (yellow – PDB 1xbl) and GrpE (red – 
PDB 1dkg). DnaK belongs to the Hsp70 family of molecular chaperones. Substrate 
binding and release by DnaK is controlled by the binding and hydrolysis of the nucleotide 
ATP to the chaperone which triggers allosteric conformational changes causing substrates 
to be released (ATP state) or bound (ADP state). DnaK is hypothesized to act on 
misfolded (of-pathway) or unfolded polypeptides. DnaJ is a co-chaperone of the Hsp40 
family; DnaJ interacts with substrate to deliver it to DnaK. GrpE is the nucleotide 
exchange factor that accelerates the removal of ADP and incorporation of ATP into 
DnaK. 
 
C- Lon protease (PDB – 4ypl) is thought to be the major proteolytic enzyme that clears 
misfolded species thus increasing the relative levels of folded proteins inside the cell. Lon 
is also proposed to degrade off-pathway misfolded intermediates (Gur and Sauer, 2008; 
Powers et al., 2012)  
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Fifth, proteins are vulnerable to competing intermolecular aggregation reactions to an 
extent that depends quite straightforwardly in vitro on the concentration of aggregation-
prone species. Aggregation also competes with folding in vivo, but translating the 
parameters and mechanistic insights from aggregation studies in vitro to the in vivo 
context must be done with caution (Figure 1.3).  
 
Figure 1.3 Schematic for a coupled folding and aggregation landscape 
 
The above figure shows the combined folding-aggregation energy landscape inside the 
cell. Unfolded protein population serves as the progenitor of all states i.e. native/folded, 
misfolded and aggregates all arise out of the unfolded state. As the protein sequence 
codes for all states, the folding and aggregation landscapes become necessarily connected 
and increasing protein concentration is a major driving force behind aggregation. Cellular 
proteostasis is maintained by chaperones and degradation enzymes that favor the 
formation of the native state and prevent the accumulation of aggregated or any other 
non-productive states. Figure adapted from Hartl et al. 2009 (Hartl and Hayer-Hartl, 
2009) and Jahn and Radford 2008 (Jahn and Radford, 2008). 
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Lastly, folding reactions in vivo are spatially organized such that some interactions will 
be preferred over others. In vitro it is very difficult to mimic a spatially organized, 
inhomogeneous environment. This point is absolutely central to the folding of membrane 
proteins, which, despite their importance, will not be a focus of this chapter. 
 
1.3. Dissecting the factors that contribute to protein folding in vivo 
1.3.1. Co-translational folding  
How co-translational folding modulates the folding landscape of proteins (the landscape 
of the whole chain, which defines the pathways to reach the native state or off-pathway 
trajectories towards aggregation from the unfolded state) of proteins has been examined 
in a number of recent experimental and computational studies. O’Brien et al. introduced a 
computational approach to explore the impact of factors such as translation rate on 
folding (Ciryam et al., 2013; Nissley et al., 2016). Their findings suggest that mutations 
in mRNA that lead to altered translation rates may markedly alter folding outcomes. In a 
follow up in the same study, this group compared folding of ribosome nascent chain 
complexes that are arrested with those that are actively translating and concluded that at 
in-vivo translation rates, one-third of E. coli proteins would fold co-translationally. 
Krobath et al. also applied computational methods and found major impact of co-
translational folding of arrested chains versus chain fragments folding freely (Krobath et 
al., 2013). They observed that the ribosome enhanced the population of low energy 
conformations dominated by local interactions. The interrelatedness of translation rate 
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and folding points to a level of selective pressure acting at the RNA level. Experiments 
with synonymous codons and ribosome display indeed point to the encoding of RNA-
level information, which might be woven together with the sequence code for folding in 
vivo. The ribosome itself has been shown to affect folding (Ingolia et al., 2013; Shabalina 
et al., 2013). Using single molecule force experiments, Kaiser et al. (Kaiser et al., 2011) 
found that electrostatic interactions between the ribosome and their test protein (T4 
lysozyme) retarded premature folding and allowed the nascent chain to remain in a 
folding-competent state. Knight et al. (Knight et al., 2013) examined the dynamics of a 
model nascent chain (a disordered protein) with varying charge and concluded that the 
ribosome surface electrostatically influenced the behavior of the chain, causing nascent 
protein variants carrying more negative charge to be more mobile. Recent studies by the 
O’Brien group demonstrate the power of a computational model that predicts changes in 
co-translational folding by the introduction of mutations in protein sequence that are 
measureable by experiments (Nissley et al., 2016). Additionally, efforts directed at 
understanding the structural aspects of co-translational folding have also revealed the role 
of the ribosome in preventing misfolding and aggregation of certain substrates (Cabrita et 
al., 2016; Deckert et al., 2016). 
 
Viewing co-translational folding in terms of a naked nascent chain exploring 
conformational space is, however, greatly oversimplified. A whole host of chaperones 
(discussed in sections below) and quality control mechanisms lie in wait to greet the 
emerging polypeptide chain and assist its folding. The nature of this ribosomally 
associated greeting committee in E. coli has been reviewed by Bukau and co-workers 
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(Gloge et al., 2014). Their studies and others have revealed the order of events upon 
‘birth’ of a nascent polypeptide, beginning with N-terminal processing, and followed by 
chaperone interactions with trigger factor, the chaperone that has privileged access to 
nascent chains of cytoplasmic proteins.  These authors have provided compelling 
arguments for an unfolding role of trigger factor, a ribosome associated chaperone, which 
interacts with nascent chains (Hoffmann et al., 2012). Single-molecule pulling 
experiments on maltose binding protein, Mashaghi et al. (Mashaghi et al., 2013) make a 
strong argument that trigger factor promotes productive folding by protecting partially 
folded states from misinteraction with neighboring molecules. The emerging role of 
trigger factor in nascent chain folding is supported by computational work from Dobson 
and colleagues, which posits that trigger factor interacts with emerging chains and retards 
folding in addition to shielding the polypeptide from unfavorable interactions (O'Brien et 
al., 2012). In eukaryotes, the Frydman lab has recently examined the co-translational 
roles of Hsp70 in yeast through a global analysis of ribosome nascent chains (O'Brien et 
al., 2012; Willmund et al., 2013). They found that Hsp70 interacted preferentially with 
large multidomain proteins of complex topology that were unlikely to be able to fold co-
translationally, consistent with the function of Hsp70 in maintaining the nascent chain in 
a folding-competent state.  
 
1.3.2. Chaperones and proteostasis 
Once a newly synthesized chain is away from the ribosome, it is further assisted by non-
ribosomally associated chaperones to ensure its successful folding and minimize 
competing aggregation processes. While data have been rapidly accumulating on the 
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client repertoire of various chaperones in vivo, much less is known about how chaperone 
interactions affect protein folding reactions. For example, recent studies have asked how 
many and which proteins in E. coli are facilitated by the major chaperone systems 
GroEL/GroES and DnaK/DnaJ/GrpE: The Hsp70 system interacts with 700 cytoplasmic 
proteins, with particularly strong interaction with a subset of 180 that are aggregation-
prone (Calloni et al., 2012). GroEL/ES was found in a proteomic study to support the 
folding of 250 proteins, with 84 of these obligatorily dependent on the chaperonin for 
folding; a recent revisiting of this question concluded that there were fewer true GroEL 
substrates (Kerner et al., 2005; Niwa et al., 2012), but the two studies agreed on the 
nature of the obligate substrates: small enough to fit in the chaperonin cavity, and 
enriched in metabolic enzymes and TIM barrels. Interestingly, Taguchi and co-workers 
(Niwa et al., 2012)found using a cell-free system that the major E. coli chaperone 
systems GroEL/GroES and DnaK/DnaJ/GrpE improved the solubility of 66% of their test 
group of 800 marginally soluble E. coli proteins. These studies have provided insight into 
the cellular dependence on chaperones for productive folding. How do chaperone-
substrate interactions sculpt folding landscapes? Single particle cryo-electron microscopy 
has provided glimpses of substrates encapsulated in the GroEL chaperonin cavity, 
suggesting that they are quite collapsed (Chen et al., 2013; Clare et al., 2009). Using in 
vivo experiments monitoring growth as a criterion for fitness when mutant versions of the 
essential protein dihydrofolate reductase were expressed in the presence of differing 
amounts of GroEL/ES or the major protease Lon, Bershtein et al. (Bershtein et al., 2013) 
concluded that both the chaperonin and the protease act on the molten globule 
intermediate. These studies are consistent with current models in which GroEL 
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smoothens the folding landscape of poor folders, while DnaK largely acts to unfold its 
substrates, or maintain folding-competent or unfolded states (Kim et al., 2013; Saibil, 
2013). There have been numerous efforts to determine the clients of Hsp90 chaperones, 
and several labs have applied biophysical methods to deduce the nature of the binding 
interaction and likely impact on substrate folding, but many questions remain for this 
chaperone as well (Taipale et al., 2012). Data suggest that Hsp90 substrates are folding 
intermediates with dynamic character. For example, p53 was observed to adopt a molten-
globule state upon interaction with Hsp90, and the model substrate staphylococcal 
nuclease has been proposed to bind Hsp90 in an unfolded state via a local structural 
element (Nissley et al., 2016). Similarly tau also interacts with multiple hydrophobic 
contacts on Hsp90 suggestive of a late folding intermediate (Karagoz et al., 2014).  The 
elegant recent single molecule study of trigger factor-substrate interactions described 
above demonstrated directly an unfolding activity – i.e. trigger factor unfolded the client 
protein to allow a refolding reaction to occur (Hoffmann et al., 2012). The interactions of 
small heat shock proteins with their clients have been a subject of constant examination, 
but here also we lack mechanistic understanding about how these chaperones affect 
folding. Similarly, the periplasmic chaperone HdeA binds molten globular substrates at 
low pH but the consequent effects on their folding are as yet unexplored (Basha et al., 
2012; Foit et al., 2013; Hong et al., 2012). Strikingly, another periplasmic chaperone, spy 
has been recently shown to allow proteins to fold while still being associated with the 
chaperone (Stull et al., 2016). The eukaryotic chaperonin, TRiC, has to deal with larger 
proteins than encountered in E. coli, and a recent study concludes that it binds partially 
folded intermediates at domain boundaries, which helps explain how it may act on 
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multidomain substrates but does not reveal details of its impact on their folding 
(Russmann et al., 2012). Recent studies pioneered by the Kay lab (Sekhar et al., 2015, 
2016) have found that DnaK keeps substrates in a more extended conformation yet 
allowing the substrate to retain some of the local secondary structure it has in the 
unfolded state. All told, current understanding of the impact of chaperone interactions on 
the folding landscapes of proteins remains incomplete, and the confluence of data and 
ideas from both in vitro and in vivo experiments will be needed to shed further light on 
this key question.  
 
Chaperones work in teams and in partnership with degradation enzymes to facilitate 
folding in vivo and maintain protein homeostasis. A recent thrust is focused on admitting 
the complexity of integrated chaperone networks to elucidate the impact on folding of a 
substrate. A kinetic model centered on the major E. coli proteostasis components 
(chaperones, degradation enzymes, disaggregase), beginning with a translated nascent 
chain, has been developed jointly by Powers' and our labs (Powers et al., 2012). This 
model called FoldEco enables generation of hypotheses about the involvement of the 
proteostasis machinery and the folding success of a polypeptide when a few in vitro 
parameters are known. Also, by implementing in vivo FRET on fluorescently labeled 
chaperones Kumar and Sourjik (Kumar and Sourjik, 2012) were able to capture some of 
the interplay between the chaperone systems in E. coli, thus showing that the quality 
control systems are not isolated, but rather synergistic. The authors show how DnaK (or 
Hsp70) seems to be a central player in the de novo and re-folding branches of the 
proteostasis system.  
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1.3.3. Evolutionary pressures  
The canonical definition of ‘the protein folding problem’–viz., how is the information for 
a protein folding landscape encoded in a given sequence– does not acknowledge the 
many selective pressures that have led to the existence of that sequence in the proteome 
of the organism from which it came. There is growing awareness of the importance of 
understanding the impact of evolutionary selection on protein sequences and 
consequently, their folding. It is not obvious when taken out of evolutionary context why 
factors such as function, turn-over interactions would change the protein folding 
landscape. Adding to the complexity is the fact that there are also many pressures acting 
on base sequences, for example to adjust translation rate and to enable regulatory 
processes to occur in transcription and translation (Li et al., 2012).  
 
Protein stability naturally appears to be a property that would be selected for during 
evolution (Serohijos et al., 2012). Using a theory-based and simulations approach, 
Shakhnovich and colleagues make a strong case of how destabilizing mutations are 
selected against in highly abundant proteins, thus explaining their slow evolutionary rate. 
Yet, proteins designed in a laboratory generally display significantly higher stability than 
naturally occurring proteins (Koga et al., 2012). This observation suggests that stability is 
not the dominant driving force for sequence selection (Reynolds et al., 2013). A protein 
must possess a number of other properties to survive a selection for organismal fitness.  
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Perhaps the most obvious evolutionary pressure that impacts folding properties is the 
requirement for function. Many have noted that the selection for folding and function 
leads frequently to a trade-off (Dellus-Gur et al., 2013; Gosavi, 2013). Tawfik recently 
noted that some folds, like TIM barrels, may possess a property, which he terms 
polarization, that enables them to adapt to new functions (innovability) while maintaining 
foldability and stability (Dellus-Gur et al., 2013).  Mechanistic impacts of the folding-
function tradeoff were postulated for interleukin-1β (IL-1β). Capraro et al. (Capraro et 
al., 2012) observed that a functionally important structural feature, in IL-1β a β-bulge, 
acts to shape the functional landscape so that only one folding route is followed, whereas 
variants in which this bulge was mutated follow multiple routes.   
 
Tawfik’s term ‘innovability’ may also apply to the ability of a protein evolutionary path 
to lead to new folds. In a very thought provoking study, He et al. (He et al., 2012) 
experimentally identified ‘mutational tipping points’ that enabled proteins to switch folds 
and evolve new functions. On the other hand a study of ancestral thioredoxin proteins by 
the Gavira group points out that although the ancestral protein differed considerably in 
sequence from the present version and was more thermo-stable, it folds into the same 
conformation as extant thiredoxins (Tokuriki and Tawfik, 2009). This highlights the 
robustness of a protein sequence to tolerate destabilizing mutations yet fold to carry out 
its function. It may well be an evolutionary advantage to retain this sequence nimbleness–
the ability to absorb mutations that may cause a change in fold or function, which may 
improve organismal fitness, and in turn will have impact on the ‘winning’ sequences we 
see in current proteomes. In a recent study with repeat proteins, Smock et al. (Smock et 
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al., 2016) arrive at the conclusion that stability is inversely correlated with function, 
which is not highly surprising given that an optimal balance between stability and 
functionality decides the outcome of the protein sequence under evolutionary pressure 
(Dellus-Gur et al., 2013; Koga et al., 2012). 
 
 
The fine tuning of protein sequences to achieve the fittest fold and optimized function do 
not operate in isolation in vivo. The idea that chaperones can buffer destabilizing 
mutations that directly improve their function, or serve as stepping-stones to proteins of 
improved function, has been experimentally supported (Tokuriki and Tawfik, 2009; 
Wyganowski et al., 2013). Mapa and colleagues (Mapa et al., 2012) performed 
experiments on a set of model substrates that populated kinetic intermediates and 
demonstrated that each selectively bound its cognate chaperone from the whole spectrum 
of E. coli chaperones present in lysate. They postulated that chaperone preferences co-
evolve with foldability of protein sequences. This notion was recently emphasized in a 
provocative review on the origins of proteostasis (Powers and Balch, 2013). Furthermore, 
the authors of this review, along with another, have pointed out that protein evolution 
under the aegis of proteostasis is also environment dependent, and that integration of all 
factors operating on an organism leads to proteomic diversity (Bogumil and Dagan, 2012; 
Powers and Balch, 2013) (Figure 1.4). 
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Figure 1.4 Evolutionary pressures changes the protein folding landscape inside the 
cell 
 
Protein folding in vitro can be thought of as navigating an energy landscape to reach from 
a high-energy unfolded state to a low energy folded state. Hills and valleys along the 
landscape represent kinetic barriers to protein folding which determine the speed at which 
a protein folds/unfolds and the energetic difference between the top and bottom of the 
landscape represents the folding free energy. In vivo the protein folding landscape is 
subject to modification by a myriad of factors which include folding, function, 
evolvability, and interactions with other biomolecules – all factors ultimately tying into 
evolutionary optimization of protein to benefit the organism. 
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Another factor that constrains sequence evolution is the requirement that proteins in vivo 
form productive interactions and avoid non-productive interactions (Pastore and Temussi, 
2012). A corollary of this selective pressure is the avoidance of pathological aggregation, 
which may be viewed as a non-productive interaction. As noted recently by Levy et al., 
(Levy et al., 2012) the constraints on evolution of proteomes imposed by the need to form 
productive interactions and to avoid non-productive interactions is enhanced under the 
crowded conditions of the cell. A computational study by Yang and co-workers 
postulates (Yang et al., 2012) that avoiding deleterious interactions causes abundantly 
expressed proteins to evolve more slowly. In addition, evolutionary trends also suggest 
that there has been a decrease in the fraction of hydrophobic residues and a tendency for 
increased disorder within the proteome over time (Mannige et al., 2012). Such changes 
may arise as a function of natural selection; however, they have consequences on folding 
and protein-partner interactions. Furthermore, organization with favorable interaction 
partners has been recently hypothesized to add to protein stability (Dixit and Maslov, 
2013). This concept is similar to that of chaperones being evolutionary buffers as 
discussed above, allowing proteins to accrue destabilizing mutations, yet fold and be 
better at their function (Tokuriki and Tawfik, 2009). 
1.3.4 Macromolecular Crowding, high density of co-solutes and quinary interactions  
• Macromolecular crowding: 
In vivo, proteins must fold and be stable in a heterogeneous environment as concentrated 
as 400 g/L (Figure 1.1). Early hypotheses about macromolecular crowding placed heavy 
		25 
emphasis on the contribution of the void volume effects and its impact on the 
enhancement of protein stability (Zhou et al., 2008). However, recent work by Pielak and 
colleagues reveals that the influence of the crowded in-vivo environment may be 
dominated by the prevalence of weak interactions, rather than the effects of excluded 
volume from macromolecular crowding, as previously believed (Miklos et al., 2011b; 
Monteith et al., 2015; Smith et al., 2016; Wang et al., 2012). These researchers found that 
protein crowding agents (bovine serum albumin, lysozyme) destabilized a test protein, 
CI2, in contrast to the stabilization expected from excluded volume effects (Miklos et al., 
2011a; Miklos et al., 2011b). Such effects are expected to be protein- and context-
dependent, and indeed Guo et al. used a novel rapid laser temperature stepping method 
capable of measuring complete thermal melts and kinetic traces in vivo to deduce that 
phosphoglycerate kinase was more stable in mammalian cells than in vitro (Guo et al., 
2012). The seemingly contrasting results may differ because the experiments were 
performed at different temperatures, and the entropic component of crowding is 
temperature-dependent (Zhou, 2013). In addition, Dixit and Maslov (Dixit and Maslov, 
2013) have argued compellingly that protein-protein interaction networks will stabilize 
proteins in vivo relative to in vitro. Recent studies performed by the Oliveberg 
(Danielsson et al., 2015) and Pielak (Smith et al., 2016) groups have provided a much 
more detailed understanding of how the cellular environment and more importantly the 
place of the protein in the a particular environment is an important factor determining 
changes to protein stability when compared to measurements made in vitro. Using 
elegant NMR experiments, the authors (Danielsson et al., 2015; Smith et al., 2016) 
determine the impact of macromolecular crowding agents, the E. coli cytosol and cellular 
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environment and the mammalian cellular environment on the stability of test proteins (the 
SH3 domain and superoxide dismutase) and arrive at the conclusion that protein stability 
in vivo is a function of multiple parameters – namely, protein surfaces, Quinary 
interactions and in general the cellular milieu that interacts with the protein of interest. 
 
• Quinary Interactions: 
Protein function also involves the formation of higher order protein structures such as 
quarternary and quinary structures (McConkey, 1982), which involve the proteins to 
productively interact with each other. These higher levels of “folding” have long been 
implicated in metabolic functions, where the resulting organized pathways were termed 
'metabolons' (Roguev et al., 2013; Velot et al., 1997) and in signaling pathways. It had 
long been hypothesized that the crowded cellular environment necessitates interactions 
among biomacromolecules, and although such weakly associated complexes are difficult 
to study in situ, and would be difficult to isolate, recent efforts have led to new methods 
to interrogate them (Fraser et al., 2013; Lane et al., 2012). A recent study from the 
Teichmann and Robinson labs (Marsh et al., 2013) utilizes nano-electrospray ionization 
and gene fusion analysis to determine how several multimeric complexes are assembled 
and disassembled. Through their analyses the authors find that the formation of 
quaternary structure and protein assembly pathways also appear to be under evolutionary 
pressure. Gruebele and colleagues (Wirth and Gruebele, 2013) have weighed in on 
terming the panoply of weak interactions influencing a protein in vivo, both specific and 
non-specific: 'quinary structure', as originally suggested by McConkey (McConkey, 
1982) and re-introduced in an earlier review (Gershenson and Gierasch, 2011). 
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• Inorganic ions and Metabolites: 
The total concentration of cytoplasmic inorganic ions in E. coli is ~300 mM according to 
the CyberCell database created by the Wishart laboratory (Sundararaj et al., 2004) . The 
concentration of K+, by far the most abundant inorganic ion, varies drastically with 
osmotic conditions. Two hundred millimolar is reported (Jewett and Swartz, 2004; 
Record et al., 1998) to be physiologically relevant and CyberCell notes a concentration 
range of 200-250 mM. Similarly, concentrations of Mg2+ have been reported, with 
estimates ranging from 20  to 100 mM, although the amount of free Mg2+ is estimated to 
be much smaller at 1 - 2 mM (Moncany and Kellenberger, 1981; Outten and O'Halloran, 
2001; Tyrrell et al., 2013). Estimates for other common inorganic ions include Na+ at ~5 
mM, Ca2+ at ~0.1 mM, and CyberCell reports concentrations of Cl- and total phosphate 
(H2PO4-/HPO42-/PO43-) at 6 and 5 mM, respectively (Outten and O'Halloran, 2001; 
Shabala et al., 2009). Although variations between tissues exist, average concentrations 
of inorganic ions in E. coli, yeast and mammalian cells are in the same range.  
Changes in intracellular ion levels can have pronounced effects on the conformational 
properties of proteins and can have detrimental effects as seen in the enhanced 
aggregation of a-synuclein at high salt concentrations (Hoyer et al., 2004). Growing 
evidence suggests that changes in metal homeostasis and altered intrinsically disordered 
proteins-metal interactions contribute to the pathogenesis of several neurodegenerative 
disorders (Botelho et al., 2012; Breydo and Uversky, 2011; Kepp, 2012) suggesting the 
critical balance that requires maintenance inside the cell. Indeed, many amyloidogenic 
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IDPs such as α-synuclein, tau or amyloid β (Aβ) peptides directly bind metals, and metal 
interactions modulate their in vitro aggregation behaviors (Theillet et al., 2014). 
 
Recent advances in metabolomics technologies have allowed the concentrations of large 
numbers of metabolites to be measured in E. coli (Bennett et al., 2009). In glucose-fed, 
exponentially growing E. coli cells the combined concentrations of metabolites have been 
estimated to be ~300 mM, with glutamate (Glu-) being the most abundant metabolite by 
far (96 mM), followed by glutathione, fructose-1,6-bisphophate and adenosine 
triphosphate (ATP) at 17 mM, 15 mM and 9.6 mM, respectively (Bennett et al., 2009). 
However, these concentrations depend on the culture medium. By changing the carbon 
source from glucose to glycerol or acetate, intracellular Glu- levels change from 96 mM 
to 149 mM, to 45 mM, respectively (Bennett et al., 2009). Similarly, intracellular 
glutathione concentrations change from 17 mM, to 18 mM, to 8 mM; Fructose-1,6-
bisphophate from 15 mM, to 6 mM, to <0.15 mM; ATP from 9.6 mM, to 9.0 mM, to 4.1 
mM (Bennett et al., 2009). Significant variations in intracellular Glu- levels due to 
changes in glucose levels in the growth media or due to changes in osmotic conditions 
have also been seen in other studies (Cayley et al., 1991; Roe et al., 1998). When E. coli 
cells were grown in McIlvaine's medium (minimal medium with citrate/phosphate buffer, 
supplemented with thiamine and glucose) at pH 6, and harvested at mid-exponential 
phase, the total concentration of all amino acids was determined to be ~90 mM, of which 
Glu- comprises ~60 mM (Roe et al., 1998). In the presence of 200 mM glucose, Glu- 
concentration increase to ~117 mM. At 400 mM glucose, it is ~160 mM. By contrast, 
CyberCell lists the combined E. coli concentrations of all 'small organic molecules' as 40-
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50 mM (undefined growth-medium and -stage), concentrations of free amino acids total 
~15 mM, and ATP is indicated between 1.3-7.0 mM, depending on growth conditions 
and sugar sources (Theillet et al., 2014). These numbers indicate the sheer abundance of 
co-solutes and metabolites, all of which can influence the stability and interactions of 
proteins inside cells. 
 
Some metabolites such as glycerol, trehalose and zwitterions such as trimethylamine-N-
oxide, proline, betaine and ectoine, stabilize proteins at intracellular concentrations 
between 100-300 mM (Bandyopadhyay et al., 2012). These compounds may represent a 
special class of metabolites, termed ‘osmolytes’ because they also function as powerful 
stabilizing agents in vitro. Nevertheless, these data indicate that metabolite concentrations 
in the range of ~300 mM are sufficient to modify the properties of individual proteins. 
While it is unlikely that metabolites generally induce folding of proteins in cellular 
environments, they may modify the structural features of some of them. Furthermore, the 
binding of these metabolites might shift the populations of proteins that exist in the 
folded/unfolded state to selectively populate one or the other. Given the fact that proteins 
with binding function are amongst the most populate class in the proteome, there remains 
little light shed on how small molecule ligands can impact the folding fate of a large 
fraction of the proteome. 
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1.4. Kinetic partitioning – folding/aggregation/chaperone binding/ligand binding: 
To understand how folding inside the cell differs from folding in vitro one has to consider 
all the different parameters that can alter the folding of a protein and the fate of the 
polypeptide chain in vivo. To fully capture the processes going on inside the cell, one has 
to understand that the polypeptide sequence is under competition from the various factors 
mentioned above. While the correct and functional folded state may be optimized by 
evolution, protein levels, avoidance of aggregation and dependence on chaperones and 
binding ligands can all be described by invoking a model of kinetic competition or kinetic 
partitioning (Figure 1.5).  
 
Figure 1.5 General schematic for the fates and the kinetic partitioning of a 
polypeptide chain inside the cell 
 
A synthesized protein (S) can fold co-translationally (not shown) or can fold to the native 
(N) state from the unfolded (U) state. The U state is the progenitor for all states inside the 
cell. The U state can misfold into an off pathway (M) state which has the propensity to 
form protein aggregates (A). The N state has the capability to bind ligands (blue star) and 
the M and U states can be degraded by cellular proteases. The transition from the U state 
to any other state, or interconversion between states is principally governed by the 
intrinsic rate constant for that conversion and the concentration of the species which acts 
as a reactant in that conversion. 
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A model of kinetic partitioning takes into consideration biophysical parameters and the 
concentrations of the interacting components and uses a set of coupled ordinary 
differential equations to establish relationships between folding outcomes and the impact 
of the cellular environment on them. For example, one of the best-described model for 
kinetic competition is FoldEco (Cho et al., 2015; Powers et al., 2012) (Figure 1.6).  
 
Figure 1.6 The FoldEco model of proteostasis and kinetic partitioning in E. coli 
 
The figure is a schematic of FoldEco which is a system of differential equations that 
computes the flux of synthesized protein through different states (folded, unfolded, 
misfolded, aggregated and degraded) in E. coli taking into consideration their intrinsic 
folding and misfolding rate constants and how these proteins interact with the 
proteostasis machinery of the cell, i.e. the association rates between different states and a 
chaperone or degradation enzyme. It is a computational system which overlays the 
chaperones and degradation machinery of E. coli on top of the kinetic competition that 
naturally occurs for protein sequence. It serves as an important tool for generating 
hypotheises as to how altering folding/misfolding properties can have an impact on the 
folding fate of a protein inside the cell. 
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FoldEco is a computational algorithm written to determine how the biophysical 
properties of a protein interface with the proteostasis components to produce a given 
yield of folded protein. The biophysical properties of the protein include the folding and 
unfolding rate constants, misfolding and aggregation rate constants and equilibrium 
constants for all those processes. The four states, folded, misfolded, unfolded and 
aggregated, are a minimal set of states states that a monomeric protein can populate after 
biosynthesis; one could add complexity by adding intermediates or treating multimeric 
proteins, which could populate different oligomeric states. The program is specifically 
written to incorporate the major components of the proteostasis machinery of Escherichia 
coli, namely the two major chaperone systems, the GroELS and DnaKJE systems, a 
disaggregation system which includes ClpB and DnaK and a mechanism for degradation 
assumed to be catalyzed by the Lon protease. The proteostasis components have the 
capacity to interact with three of the four possible states a protein can populate. The 
interaction between the unfolded and misfolded states and the chaperone systems and 
Lon are defined by association rate constants and the association of the aggregated state 
with the disaggregation machinery is similarly defined. The program integrates all these 
processes as coupled differential equations which when solved yield a theoretical output 
of what to anticipate under a defined set of folding and proteostasis conditions. I will 
discuss chaperone binding and the dependence of some proteins on chaperones to fold in 
Chapter 3. By understanding how the protein partitions between folded and aggregated 
states and with the knowledge of the chaperone concentrations, one should be able to 
understand the impact of the proteostasis components on the folding of a test protein. 
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Important, yet not fully captured by FoldEco is the impact of the metabolites and ligands 
on the folded state of the protein. As mentioned earlier, ligand binding has the capacity to 
shift the equilibrium that exists between different protein states in vivo. FoldEco also has 
been focused initially on the fate of a single protein, but the program has the capacity to 
consider competition among different folding clients for the protein homeostasis network. 
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1.5 Statement of thesis 
Despite the advances made in the field of protein folding, understanding how protein 
folding properties interface with the complex cellular milieu remains insufficiently 
studied. Most of our quantitative knowledge on folding comes from studies performed on 
small well-folded proteins in dilute and purified environments. This approach, while 
revealing the minutiae of the folding pathway, does not fully capture what could be 
occurring inside the cell. Specifically, such studies do not capture the essence of kinetic 
partitioning: protein sequences are have several possible pathways they can follow, 
folding, aggregation, degradation, and the fate of the polypeptide chain depends on both 
the intrinsic biophysical properties that govern the states a synthesized protein will visit 
and how the cellular quality control machinery interacts with a synthesized polypeptide 
chain so as to sculpt its landscape to favor folding and reduce detrimental outcomes. In 
this thesis, we use a combined approach of experimental testing and mathematical 
modeling to examine two aspects of the cellular environment that could affect the 
successful folding of a synthesized protein . In Chapter 2, we dissect quantitatively the 
effect of ligands on the folding fate of the protein. Our investigation seeks to capture 
what could be happening to populations of multiple states that can be occupied by 
synthesized protein in the presence of a high affinity ligand. We hypothesize that ligand 
binding occurs after the protein successfully folds and that binding prevents non-
productive outcomes such as aggregation by effectively lowering the rate at which the 
protein unfolds and populates an aggregation-prone state. We also hypothesize that the 
remediation provided by the binding of the ligand is dependent on the relative 
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biophysical properties of the protein and how it is the competition between populating the 
folded state versus non-productive states that determines how effective the ligand, would 
be. We further test our hypothesis using a system pertinent to human disease and where 
protein degradation can be alleviated using a high affinity small molecule, an intervention 
now dubbed pharmacological chaperone therapy. In Chapter 3, we investigate why 
certain proteins obligatorily require the aid of chaperones to successfully reach the folded 
state. To understand this, we utilized a test protein that obligatorily relies on one of the 
chaperone systems to correctly fold and investigate how this protein’s folding outcome 
changes when we alter the availability of different chaperone systems and degradation 
machinery to the protein upon synthesis in the cell. Specifically, we work in E. coli, and 
manipulate its two major chaperone systems, the GroELS and DnaKJE systems, and a 
major degradation system (the Lon protease). We work in E. coli because it is a simple 
organism with approximately 4000 genes and is capable of being grown and manipulated 
to express varying amounts of protein in a facile manner. Using the above-mentioned 
FoldEco model of proteostasis kinetic partitioning to explain the observed experimental 
folding fate of the protein we deduced what the folding, misfolding and aggregation 
parameters for such a chaperone-dependent protein were; parameters, which would not be 
easy to measure in in vitro environments. Combining modeling results with experiments 
monitoring the folding fate of our test protein, we were able to understand how ligands 
and the intrinsic biophysical properties of a protein that obligatorily depends on cellular 
proteostasis machinery affect the folding outcome of a protein to reach the folded state, 
thus shedding light on the processes that govern protein folding inside the cell. In chapter 
four we use our knowledge on ligand binding and enhancement of stability to build a 
		38 
protein folding sensor to measure protein thermodynamic stabilities inside the cell. We 
discuss one approach for building such a sensor, the mutually exclusive folding model 
and show how it can be implemented using a suitable protein – ligand pair as a starting 
point for our sensor. We then go on to show preliminary experiments that utilize our 
folding sensor in vitro and in vivo to demonstrate that such a construct can theoretically 
be used to test protein stability and the limitations associated with the use of a mutually 
exclusive folding construct as a sensor for protein stability measurements. 
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CHAPTER 2 
INVESTIGATINGT THE IMPACT OF SMALL MOLECULES ON PROTEIN 
FOLDING INSIDE THE CELL 
 
This chapter investigates how the presence of a high affinity ligand biases the 
competition between folding and aggregation to favor the folded state, thereby reducing 
the effective unfolding rate and preventing the channeling of protein into non-productive 
pathways such as aggregation or degradation. The work for this chapter was performed in 
collaboration with Matthew Metcalf, Scott Garman and Evan Powers, and has been 
submitted for publication. 
 
2.1. Introduction 
Cellular proteins are bathed in a sea of diverse ligands ranging from other 
macromolecules to metabolites. The intracellular concentration of macromolecules is 
high, up to 400 mg/ml in bacteria and eukaryotic organelles, and small molecules such as 
metabolites are also present at high concentrations inside cells. For example, in glucose-
fed E. coli, glutamate, ATP, glutathione, NAD+ and other metabolites are present at 
millimolar levels (Bennett et al., 2009; Gershenson and Gierasch, 2011). Thus, in a 
normal physiological milieu proteins participate in binding reactions and equilibria with 
many other intracellular solutes; these binding interactions range from strong, specific 
interactions to weak, transient interactions.  Surprisingly, little attention has been paid to 
the impact of these many binding interactions on the folding energy landscapes of 
proteins in the cell, despite active research directed towards enhanced understanding of 
protein folding in cells (Bershtein et al., 2015; Bershtein et al., 2013; Cho et al., 2015; 
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Dixit and Maslov, 2013; Hingorani and Gierasch, 2014; Kim et al., 2013; Monteith et al., 
2015). It is in the intracellular environment that is replete with co-solutes that proteins 
must successfully navigate an intersecting folding – aggregation landscape to reach their 
functional folded states (Jahn and Radford, 2008). In addition, small molecules added to 
cells exogenously as potential therapeutics will influence the folding – aggregation 
landscape. In the present study, we have explored the impact of ligand binding on folding 
in the cell using two simple test systems, combining experimental and mathematical 
modeling approaches to gain insight into the magnitude of the effect of ligand binding on 
the partitioning of the test protein between proper folding and aggregation.  
 
2.2. An aggregation-prone dihydrofolate reductase mutant can be rescued using a 
high affinity ligand 
To determine the effect of a high affinity ligand on the kinetic balance between folding 
and aggregation, we chose to work with a destabilized version of E. coli dihydrofolate 
reductase (dDHFR) as our test protein. dDHFR was destabilized by the introduction of 
two glycine residues in a surface loop between residues 106 and 107 (Figure 2.1A). The 
mutation did not perturb any residues in the ligand-binding site. We tested the affinity for 
the ligand trimethoprim using an intrinsic (present in the DHFR molecule) tryptophan 
fluorescence quenching assay (see methods) and found that the our mutation had only 
slightly perturbed affinity for this ligand (approximately 40 nM compared to 8 nM as 
reported in literature by (Watson et al., 2007)) (Figure 2.1C).  Upon over expression in E. 
coli BL21(DE3) cells, dDHFR largely (80%) aggregated in the absence of any added 
ligand. Strikingly, the presence of a non-hydrolysable analog of the natural DHFR 
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substrate trimethoprim (TMP) during protein synthesis re-partitioned the protein to the 
soluble fraction to a large extent (Figure 2.1D).  
In vitro characterization of dDHFR revealed a ΔΔG of approximately 3 kcal/mol with 
respect to wild type (Figure 2.1B) (Ionescu et al., 2000) at 37 o C. The equilibrium free 
energy of unfolding was determined as a function of increasing concentration of 
trimethylamine N-oxide (TMAO) by performing urea denaturation experiments at desired 
concentrations of TMAO. Extrapolating the free energy to 0 TMAO allowed us to 
calculate the ΔG to be about 0.5 kcal/mol at 37 o C (the equilibrium stability measured by 
urea denaturation experiments of wildtype DHFR measured at 37 o C was reported at 3.5 
kcal/mol) . This translates to roughly 70% of the protein population being folded at 
equilibrium, suggesting that the protein tended to significantly populate the unfolded state 
even at equilibrium. Together with our in vitro and protein expression data, the dDFHR-
TMP seemed to be an ideal model system to test the impact of a high affinity ligand on 
the kinetic partitioning between folding and aggregation. 
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Figure 2.1 dDHFR is a destabilized test protein the solubility of which is improved 
upon addition of a high affinity ligand trimethoprim. 
  
A. Test protein dDHFR (PDB 7dfr) with a gly-gly insertion between residues 106 and 
107 (highlighted in red) and the cognate ligand trimethoprim, which mimics substrate and 
is a competitive inhibitor.  
 
B. Fluorescence quenching of dDHFR (50 nM) upon titration with TMP enables the 
calculation of the fraction of dDHFR that is bound at each TMP concentration. The error 
bars for the individual data points represents the standard error of the mean from 
triplicate measurements. Fitting single site binding model to the data yields an estimated 
equilibrium dissociation constant (Kd) of 37 ± 6 nM. The error in Kd is the standard error 
of the best fit parameter based on the fit to the averaged data.  
 
C. Stability of dDHFR was measured at varying TMAO concentrations as a function of 
urea concentration. Extrapolation from stabilities measured at different TMAO 
concentrations yields ΔG (folding free energy) at 37 oC to an average of 0.5 kcal/mol 
which is a ΔΔG of ~ 3 kcal/mol compared to wildtype (Ionescu et al., 2000). 
 
D. dDHFR synthesized in the absence of ligands partitions predominantly to the 
aggregated fraction, however presence of the high affinity ligand trimethoprim (0.8mM 
in the above sample) redistributes dDHFR to now be mostly soluble. 
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2.3. Testing the reversibility of aggregation and ligand binding inside the cell 
We next tested if the effect of TMP had to do with prevention of dDHFR from forming 
aggregates, or whether the ligand caused a rescue from the aggregated state. Secondly, 
we also wanted to determine if the dDFHR-TMP complex formed inside cells was 
essentially irreversible formed on the time scale of our experiments, or transient and 
readily dissociated. We performed chloramphenicol shut-off experiments to answer both 
questions (Aakre et al., 2013). We shut off translation using chloramphenicol and 
replaced the media containing TMP with fresh media containing no TMP. We 
hypothesized that if the dDHFR-TMP complex dissociated, then we would observe a rise 
in the aggregated fraction of the protein. Similarly, we shut off translation in the presence 
of high concentrations of TMP (80 µM). As TMP is added to the outside of cells, it acts 
as a large reservoir of ligand. Our hypothesis in this case was that if the aggregates of 
dDHFR were disaggregated and re-dissolved upon addition of TMP, we would observe 
an increased level in the soluble protein even after the protein had aggregated inside the 
cell. Both treatments were allowed to proceed for an hour before interrogating the soluble 
and insoluble fractions (Figure 2.2). From both experiments we could conclude that on 
the time scale of our experiments, the dDHFR-TMP complex was stable in cells (no 
increase in aggregates upon depletion of TMP) and that the aggregate that formed could 
not be re-dissolved by the addition of high TMP concentrations, indicating a lack of 
rescue from the aggregated state (Figure 2.2). Our model could now treat these two 
processes (aggregation and ligand binding) as irreversible. 
		46 
 
Figure 2.2 Chloramphenicol shut-off experiments indicate the effective 
irreversibility of ligand binding and aggregation 
 
A. The partitioning of dDHFR in the presence of TMP before and 1 hour after stopping 
translation with chloramphenicol (CAM). T = total dDHFR in all forms; P = aggregated 
dDHFR in the pellet after centrifugation at 18,000×g for 30 min; S = soluble dDHFR in 
the supernatant after centrifugation at 18,000×g for 30 min. Gels were stained with 
Coomassie G-250. The numbers above each lane are the mean ± standard error in the 
fraction of protein present in the corresponding states for three trials. In the presence of 
TMP, the protein found in the aggregate does not redistribute to the soluble fraction over 
the 1 hour.  
 
B. As A, but showing the partitioning of dDHFR in the presence of TMP, and 1 hour 
after stopping translation and changing the media to remove TMP. Removal of the TMP 
does not re-partition the soluble dDHFR into the aggregate fraction over 1 h. The 
associated bar graphs show the average aggregated and soluble fractions of three 
measurements and the associated standard error of the mean. 
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2.4. A mathematical model allows us to hypothesize the effect of high affinity ligands 
on the kinetic partitioning of their cognate proteins (developed by Evan Powers) 
In the model in shown in Figure 2.3, the protein is synthesized at a rate σ (µM s−1) and 
released from the ribosome in an unfolded state (U), which can fold reversibly to the 
native state (N) with folding and unfolding rate constants kf and ku (both s−1), 
respectively. The unfolded state can also aggregate through visiting some off-pathway 
misfolded intermediate which rapidly self associates to form aggregated protein (Agg). 
Each of these processes is treated as being irreversible (based on our chloramphenicol 
shut-off assays and the fact that degradation is an irreversible process) and having a first-
order rate limiting step with the rate constant kagg (s−1). The native state can bind to a 
ligand to form a complex (N:L). Again based on our controls (described in the previous 
section), we treat this process as irreversible, with a second-order association rate 
constant ka (µM−1 s−1). The model described here is not just limited to a competition 
between folding and aggregation but in general competition between folding and other 
pathways a polypeptide chain can visit inside the cell. Shown in Figure 2.3 is also the 
competition between folding and degradation (for example, Endoplasmic Reticulum 
Associated Degradation, ERAD) where again, the unfolded population of the protein is 
the progenitor to states that are degraded (Deg) with a rate constatn kdeg (s-1) . As 
degradation is intrinsically an irreversible process, we can account for it in the same 
fashion we used for the cytosolic folding – aggregation competition. Finally, the native 
state (free or ligand bound) can in some cases (depending on the organelle of interest) be 
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secreted with a first-order rate constant ksec (s−1). We assume that the turn-over rate of 
secreted protein (Sec) is much longer than the time scale of the experiment so that 
degradation after secretion is negligible. Also, we assume that the intracellular 
concentration of any ligand that is present is constant because there is a large reservoir of 
ligand in the media and the ligands rapidly equilibrate across the cell membrane. Thus, 
the “terminal states” in this model, that is, the states in which protein will continue to 
accumulate indefinitely, are the degraded, aggregated, and secreted states. If there is no 
secretion, then the ligand-bound native state (N:L) will be a terminal state rather than the 
secreted state.  
We thank Evan Powers for generously providing the mathematical rigor to our model and 
the detailed steps are noted in the appendix. 
The	fraction	of	protein	that	remains	soluble	(i.e.,	is	not	degraded	and	does	not	aggregate)	at	a	given	time	is	straightforward	to	measure	experimentally.	We	refer	to	this	quantity	as	Fr.	We	replace	Fr	with	either	Fsoluble	or	Fpreserved	depending	on	the	competition	(folding	vs	aggregation	or	folding	vs	degradation)	under	investigation.	When	a	ligand	is	present,	the	system	rapidly	reaches	a	“pseudo-steady	state”	in	which	the	concentrations	of	U	and	N	are	constant	and	Deg,	A,	N:L,	and/or	Sec	accumulate	at	a	constant	rate.	Fr	can	then	be	written	as	follows     
𝐹! = 1 − ! !! !"# !!!"! ! = 1 − !!!!! !!! !!!!!! !                                                        (1) 
Where	[A]t	and	[Deg]t	are	the	concentrations	of	aggregated	and	degraded	protein	at	time	t;	[Ptot]t	is	the	total	concentration	of	protein	that	has	been	synthesized	at	time	t;	
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[L]	is	the	ligand	concentration;	B1	=	kf/(kagg	+	kdeg);	B2	=	ksec/ku;	and	B3	=	ka/ku.	In	the	absence	of	a	ligand,	pseudo-steady	state	is	reached	more	slowly	and	Fr	is	time	dependent.	An	approximate	expression	for	Fr	under	these	circumstances	is:		
𝐹!| ! !! = 1 − !!!!! !!!!!! + !!!! !!!!!!!! !!!!!! − 1 	 	 	 	 		(2)	
 
This	expression	does	not	hold	at	early	time	points,	but	the	approximation	improves	with	time	as	the	system	approaches	steady	state	(see	Appendix).	Equation	(2)	becomes	identical	to	equation	(1)	with	[L]	=	0	at	very	long	times	(kut	>>	1).	Equation	(1)	provides	a	framework	for	understanding	the	effect	of	ligand	binding	on	protein	partitioning	to	folding,	degradation	and	aggregation	in	vivo.	Importantly,	it	predicts	that	Fr	increases	with	the	ligand	concentration	until	it	reaches	the	following	limit:	𝐹!|[!]→! = 𝐹!,!"# = 1 − !!!!! = 1 − !!! !!!!""!!!"#	 	 	 																	(3)	Thus,	at	very	high	ligand	concentration,	a	protein’s	partitioning	becomes	purely	a	matter	of	kinetics	and	is	no	longer	dependent	upon	folding	thermodynamics.	Specifically,	Fr	is	controlled	by	the	relative	values	of	kf	vs.	kagg	+	kdeg.		 	
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Figure 2.3 General schematic of the kinetic partitioning influenced by ligand 
binding  
  
The schematic describes the kinetic partitioning of a protein upon synthesis in the 
presence of a high affinity ligand. The species in the model are: U, unfolded protein; N, 
natively folded protein; N:L, ligand bound natively folded protein; Deg, degraded 
protein; A, aggregated protein; Sec, secreted protein. The total protein synthesized, Ptot, 
includes all of these states. The rate constants are: σ, protein synthesis rate (µM s−1); kf, 
folding rate constant (s−1); ku, unfolding rate constant (s−1); ka, protein–ligand association 
rate constant (µM−1 s−1); kdeg, degradation rate constant (s−1); kagg, aggregation rate 
constant (s−1); ksec, secretion rate constant (s−1).  				
	 	
Synthesis U
A
aggregation secretion
folding binding
degradation
N N:L
σ kf +L
ku ka
kagg
SecDeg
kseckseckdeg
		53 
	
 
2.5. Testing the hypothesis of an upper limit on aggregation prevention in the DHFR 
–TMP system. 
We tested our model by titrating increasing concentrations of TMP into cells expressing 
dDHFR. As described by equation 1, we saw a titratable rise in the Fr as a function of our 
ligand concentration up to a certain limit beyond which any addition of ligand does not 
cause any increase in the amount of protein that aggregates or remains soluble (Figure 4).  
Given our observations, it is reasonable to conclude that the parameters from the fit of 
equation (1) accurately reflect the biophysical properties of dDHFR inside the cell. Of 
particular interest is the value of B1, which is 2.9 ± 0.8 = kf/(kagg + kdeg) = kf/kagg (the 
BL21 strain of E. coli lack Lon protease which is mainly responsible for DHFR 
degradation (Bershtein et al., 2013; Cho et al., 2015), so kdeg = 0), because it reveals that 
folding is about three times faster than aggregation. According to equation (3), this ratio 
controls the maximum extent to which TMP can rescue the folding of dDHFR. No matter 
how high the concentration of TMP is, a portion of the dDHFR will be diverted to 
aggregation before TMP binding can rescue it; for dDHFR, that portion is about 25% 
(Figure 2.4B). 
 
The dDHFR expression experiments were 90 min long (t = 5400 s). Given that B1 = 2.9 ± 
0.8 and that Fr|[L]=0 = 0.15 ± 0.02, equation (3) can be solved for ku to yield ku = 0.0035 ± 
0.0010 s−1. This value of ku is consistent with unfolding rate constants measured for other 
destabilized DHFR variants. However, it should be noted that dDHFR can bind to a 
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second ligand, the coenzyme NADPH. The effects of this ligand on dDHFR’s behavior 
are subsumed into the folding energetics, and in particular into the effective unfolding 
rate constant. 
 
 
Figure 2.4 Titration of TMP shows that dDHFR Fr scales with concentration of 
TMP and plateaus as a function of its intrinsic folding and aggregation rate 
constants 
 
A. SDS PAGE gels showing that the titration of TMP shifts the dDHFR population from 
mostly aggregated to mostly soluble in a dose dependent manner.  
 
B.  A plot of Fr vs. TMP concentration after expression for 90 min in E. coli BL21 (DE3) 
cells at 37 °C (open circles). The solid curve is the fit of equation (40) to the data with 
B1( kf/(kagg + kdeg)),  = 2.9 ± 0.8, B3 = 0.048 ± 0.025 µM−1, and R2 = 0.84. The value of Fr 
at [TMP] = 0 is shown as a filled red circle. The dashed line represents the maximum 
value of Fr according to equation 
  
		55 
 
 
 
A.  
 
 
 
B. 
 
 
  
T P
0 +M
0 
+
M
0.
1 
+
M
1 
+
M
2 
+
M
5 
+
M
10
 +
M
25
 +
M
50
 +
M
10
0 
+
M
La
c
[TMP] =
[1-DGJ]
dDHFR
a-GAL
2 +M 5 +M 10 +M 20 +M 40 +M 60 +M 80 +M 100 +M
S T P S T P S T P S T P S T P S T P S T P S T P S
a
b
d
D
H
F
R
 F
r
_
 -
 g
a
l F
r
TMP]+M
1-DGJ]+M
		56 
 
 
2.6. Testing the model on a pharmacological chaperone – The alpha galactosidase 
and DGJ model 
The chemical chaperone 1-deoxygalactonojirimycin (DGJ) is currently under 
investigation as a pharmacological chaperone therapy for Fabry disease (Benjamin et al., 
2009; Khanna et al., 2010; Wu et al., 2011). DGJ has been shown to increase the cellular 
concentrations and activity of several disease related α-galactosidase (α-GAL) point 
mutants in cell culture experiments (Benjamin et al., 2009; Wu et al., 2011). We reasoned 
that the intracellular rise in protein concentration was a manifestation of the impact of 
ligand binding on the kinetic competition between folding and degradation for the mutant 
α-GAL proteins. We tested the effect of increasing concentrations of DGJ on the 
intracellular protein levels of α-GAL R301Q (a mutation associated with late onset Fabry 
disease) in HEK cells (Fig 2.3A,B). Predictably, the levels of α-GAL increase with 
increasing concentrations of the pharmacological chaperone until a saturation point, 
analogous to what was observed in the DHFR experiment (Figure 2.5). To determine the 
level of α-GAL in the absence of any degradation we used the proteasome inhibitor 
lactacystin in one of our samples. Predictably, when compared to the sample with the 
added proteasome inhibitor, the levels of α-GAL increase with increasing 1-DGJ 
concentrations until a saturation point is reached (Figure 2.5A), analogous to what was 
observed in the dDHFR experiment and consistent with the predictions of equation (1). 
 
		57 
α-GAL R301Q does not aggregate intracellularly (kagg = 0), B1 = 1.24 ± 0.08 = kf/(kagg + 
kdeg) = kf/kdeg, indicating that degradation and folding are almost evenly poised. 
According to equation (1) and using this value of B1, the maximal rescue possible for α-
GAL R301Q is approximately 55% of the protein. Unlike dDHFR, the best fit of equation 
(1) to the α-GAL R301Q expression data is still very good at low ligand concentrations, 
indicating that the system reaches pseudo-steady state over the 24 h time course of these 
experiments (Figure 2.5B). 
 
Figure 2.5 Titration of DGJ shows that α-Gal Fr scales with concentration of DGJ 
and plateaus as a function of its intrinsic folding and degradation rate constants 
  
A. Western blot showing the increase in alpha galactosidase levels upon titration with 
DGJ, lac is proteasome inhibitor lactacystin as our 0 degradation sample to which the 
increase in protein concentration brought about by the ligand is compared to. The 
different bands observed represent the differentially glycosylated species. 
  
B. A plot of Fr vs. 1-DGJ concentration after expression for 24 h in HEK 293T cells at 37 
°C (open circles). The solid curve is the fit of equation (1) to the data with B1 = 1.2 ± 0.2, 
B2 (ksec/ku) = 0.33 ± 0.11, B3 = 0.14 ± 0.10 µM−1, and R2 = 0.88. The value of Fr at [1-
DGJ] = 0 is shown as a filled red circle. The dashed line represents the maximum value 
of Fr according to equation (3) 
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2.7. Conclusions about ligand binding 
This study has broad implications for how pharmacological chaperones function and may 
provide explanations in cases where they do not ameliorate protein misfolding diseases 
where the ratio of the folding rate constant to the sum of the aggregation and degradation 
rate constants is less than one. Migalastat (DGJ) is a well known pharmacological 
chaperone that improve the folding of the α-galactosidase mutants implicated in Fabry 
disease, respectively (Benjamin et al., 2009; Ishii et al., 2007). However, there are many 
variants of these proteins that are unresponsive to pharmacological chaperone therapy 
(Wu et al., 2011). We posit that a simple mechanism that invokes increased 
thermodynamic stability upon ligand binding is not sufficient to explain how such 
molecules work. To completely understand the mode of action of pharmacological 
chaperones it is imperative to understand the kinetic partitioning between productive 
(folded) and non-productive (aggregated/degraded) outcomes. We argue that 
pharmacological chaperones would be most effective on proteins where the rate of 
folding is not the limiting step, i.e. the protein needs to fold faster than it aggregates or is 
degraded so that the small molecule can bind it and prevent the partitioning into non-
productive states. Thus, to put forward a molecule as an effective pharmacological 
chaperone requires knowledge of how the molecule alters the kinetic competition of the 
protein it targets rather than just the affinity with which it binds. 
 
A case in point is the limited success of pharmacologic chaperones as monotherapies for 
cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane 
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conductance regulator (CFTR) (Clancy et al., 2012). CFTR is a large membrane protein 
that folds very slowly, and as a result a substantial fraction of even wild type CFTR is 
degraded before it can be exported (Lukacs et al., 1994). This situation is worse for 
CFTR mutants, many of which partition almost exclusively to ERAD leading to loss of 
CFTR function (Lukacs et al., 1994; Ward et al., 1995). Treating cells expressing a 
common disease-associated mutant (ΔF508 CFTR) with lumacaftor, a small molecule 
that binds CFTR, modestly increases the trafficking of CFTR to the cell surface (to 14% 
of wild type levels) (Van Goor et al., 2011). In terms of our model, this “low ceiling” for 
the efficacy of a pharmacologic chaperone for ΔF508 CFTR is an unavoidable 
consequence of its slow folding, and it suggests that alternative strategies for improving 
ΔF508 CFTR trafficking—for example, using proteostasis regulators either to increase kf 
(by improving chaperoning) or decrease kdeg (by inhibiting ERAD)—could yield 
improved results (Powers et al., 2009). 
 
The influence of ligand binding on the energy landscapes for folding and 
aggregation/degradation is a widespread phenomenon in nature, and ligands often 
shepherd a protein towards well-folded states. For example both antibody heavy chain 
and light chain diseases are caused by insufficient amounts of their binding partners. 
Similarly, β-2 microglobulin aggregation is triggered by its dissociation from the heavy 
chains of MHC ClassI molecules (Eichner and Radford, 2011). Ligand binding can also 
cause transitions from an unfolded state to a more ordered state. In an elegant study 
Daniels et al. (Daniels et al., 2014) demonstrate how the ligand pyrophosphate drives a 
conformational change of the disordered protein Bacillus RNaseP from unfolded to 
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folded. Such binding of ligands can provide an additional layer of protection against 
aggregation as seen in the case of Tau, where the microtubule binding region and the 
region implicated in aggregation are the same (Mukrasch et al., 2005). Lastly, the impact 
of binding on the ability of proteins to withstand mutations without succumbing to 
deleterious consequences places ligands in the category of “evolutionary buffers”; in the 
same manner as chaperones, ligands may allow proteins to mutate via steps that would 
otherwise be highly risk prone in an evolutionary pathway (Gershenson et al., 2014). To 
this effect a small summary of examples where ligand binding alters the kinetic 
partitioning of proteins between folding and non productive states such as aggregation or 
degradation is listed in Figure 2.6. 
 
 
Figure 2.6 Other prominent studies showing how natural and artificial ligands bias 
the folding – aggregation – degradation kinetic competition for other proteins  
 
The above table shows a few representative examples of how ligands have shown to alter 
the aggregation or degradation of the proteins they bind to. Essentially, the presence of a 
ligand is shown to favor the folded form, but our analysis shows that this is only possible 
because folding is not the rate limiting step for these proteins. 
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2.8. Materials and methods 
• Cloning, expression, and purification of dihydrofolate reductase.  
The wild type cysteine-free E. coli dihydrofolate reductase (DHFR) gene was a gift from 
the Matthews lab (University of Massachusetts, Medical School, Worcester MA) 
(Ionescu et al., 2000). It was subcloned into the pET28 expression vector using NdeI and 
BamHI  restriction endonuclease sites. The -glycine-glycine- insertion between residues 
K106 and A107 was introduced by site-directed mutagenesis using a QuikChange 
protocol (Stratagene) yielding the “dDHFR” mutant. The vector was transformed into E. 
coli BL21 (DE3) cells. Cultures were grown at 37 °C to optical density at 600 nm 
(OD600) of 0.6, induced with 1 mM final IPTG concentration and expressed at 37 °C for 4 
h. The cells were harvested by centrifugation and re-suspended in buffer containing 20 
mM HEPES, pH 7.4. The cells were lysed using a microfluidizer, and the protein was 
purified by refolding from inclusion bodies. Inclusion bodies were dissolved in 8 M urea 
and subsequently dialyzed to refold the protein, which was further purified using anion 
exchange chromatography on a DEAE column using a 0 M to 1 M sodium chloride 
gradient. After elution, the salt was removed by dialysis and the protein was flash frozen 
and stored at −80 °C until further use. 
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• In vitro trimethoprim binding assay for dDHFR.  
The in vitro trimethoprim (TMP) binding assay was performed with 50 nm purified 
dDHFR following the protocol from Watson and co-workers (Watson et al., 2007). 
Briefly, dDHFR was incubated with increasing concentrations of TMP and the degree 
of quenching of dDHFR intrinsic tryptophan fluorescence was monitored at 345 nm. 
Spectra were corrected for any contribution to the fluorescence by TMP by running a 
parallel titration without protein. Fraction bound was calculated by using the formula 
below. 
 
Fbound =
fluorescencemeasured − fluorescencemax
fluorescencemin − fluorescencemax  
 
• Measurement of dDHFR thermodynamic stability. 
dDHFR was titrated with increasing concentrations of urea (0 – 8 M) in the presence of a 
final TMAO concentrations of 0.7, 0.8, 0.9, 1, 1.2 and 1.5 . The titrated samples were 
incubated at 37 o C over 10 hours. Fluorescence was collected from 320 to 380 nm after 
specific tryptophan excitation at 295 nm. Intensity at wavelength 344 nm was used to fit 
the data to the two-state equation (Bolen and Santoro, 1988) to obtain thermodynamic 
stability. All solutions were prepared with 20 mM HEPES pH 7.4, and the urea 
concentration was measured using its refractive index.
 
 
Cell growth, protein induction and partitioning for dDHFR expression experiments.  
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For all experiments involving partitioning of dDHFR, E. coli BL21(DE3) cells were 
grown in LB medium until mid-log phase (OD600 = 0.6). Cells were induced with 1 mM 
final IPTG concentration for 90 minutes. All growth and induction was performed at 37 
°C. The cells were harvested after equalization for OD600 by centrifugation at 4,000 x g 
for 2 minutes, the media was discarded, and the cells were lysed using BPER-II reagent 
at room temperature for 10 minutes with 1µg/ml final DNase I added to the lysis mixture. 
The sample was then centrifuged at 18,000 x g for 30 minutes to separate insoluble 
(pellet) and soluble (supernatant) components. The samples were subsequently prepared 
by boiling in SDS running buffer for running on 12% SDS-PAGE gels. 
 
• TMP titration in E. coli cultures.  
TMP was dissolved in 100% methanol and then diluted to the desired concentration in 
media immediately after the addition of IPTG. Final methanol concentration did not 
exceed 7% v/v at the end of the experiment. Cells were harvested and partitioned as 
mentioned above. 
 
• Chloramphenicol shut off experiments. 
Protein was induced for 90 minutes in the presence of 80 µM TMP. A fraction of the cells 
was harvested before any chloramphenicol was added and a second sample was collected 
after an hour of incubation with chloramphenicol at a final concentration of 50 µg/ml. 
The partitioning measurements were performed as described above. For the change of 
media experiment, a fraction of cells was harvested after the 90 minute induction of 
DHFR in the presence of 80 µM TMP. The remaining cells were centrifuged for 10 
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minutes at 4000 x g, washed with equal volume LB, centrifuged again and resuspended in 
LB supplemented with chloramphenicol at 50 µg/ml without any TMP. The second 
sample was collected after an hour of incubation with chloramphenicol and processed as 
described above. 
 
• Mammalian cell growth, and experiments with α-galactosidase.  
We seeded 10 cm culture dishes with HEK 293T cells and allowed them to reach ~80% 
confluency at 37 °C, 5% CO2. We then transfected the cells with the R301Q α-GAL 
pCMV 3xFLAG-14 (R301Q α-GAL) vector using Lipofectamine 2000. At 24 hours post-
transfection we trypsinized the cells and used the resulting suspension to seed 6-well 
plates for the DGJ titration experiment. The cells were allowed to adhere over a 4 hour 
incubation period, after which desired amounts of 1-deoxygalactonojirimycin (DGJ) or 
lactacystin (20 µM final concentration) were added. After 24 hours the cells were washed 
thoroughly with PBS, then lysed with ice cold lysis buffer (1% Triton X-100 in PBS). 
The lysate was centrifuged at 18,000 x g for 30 minutes and the soluble fraction was used 
for analysis. The samples were normalized prior to loading using the biscinchoninic acid 
(BCA) protein quantification method to ensure that equal amounts of protein were loaded 
in each case. The western blot was performed using as primary a polyclonal rabbit 
antibody against human α-GAL (purchased from GeneTex).  
 
• Gel band quantification.  
SDS-PAGE gels were stained with Coomassie G-250, scanned and analyzed on the LI-
COR ODYSSEY CLx and quantified using the associated image studio software (version 
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4.0) (Luo et al., 2006). Western blots for the α-GAL experiments were similarly 
analyzed. 
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CHAPTER 3 
INVESTIGATING THE IMPACT OF THE PROTEOSTASIS NETWORK ON 
THE FODLIGN OF AN OBLIGATE CLIENT IN VIVO 
  
This chapter describes my investigation of the folding, misfolding and aggregation 
properties of an obligatory chaperone client protein inside the cell. Using a combinatorial 
approach of computational modeling and experiments designed to test the impact of 
chaperones on the folding of the client protein at varying expression levels we have 
uncovered how such proteins fold in vivo. The work in this chapter was in collaboration 
with Todd Morse, Ha Dang and Evan Powers 
 
3.1. Chaperone assisted protein folding inside the cell 
Besides aiding in stress responses, preventing protein aggregation and at times reversing 
it, molecular chaperones often play a vital role in protein folding (Kim et al., 2013). An 
important aspect of protein folding inside the cell is the dependence of certain proteins on 
molecular chaperones to attain the native/folded state. This reliance on chaperones, which 
involves a physical interaction with the chaperones steers the protein away from 
deleterious aggregation states and towards a more productive native state. As one can 
now imagine a kinetic competition for protein sequence (see Chapter 1), chaperones bias 
the competition to favor the formation of the native state from the unfolded state (which 
we consider the progenitor of all states inside the cell). In our model organism E. coli 
there are two major chaperone families that can selectively favor folding over non-
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productive outcomes such as degradation and aggregation. The first is the Hsp60 family 
member GroEL and its co-chaperone GroES (Kerner et al., 2005; Kim et al., 2013). This 
chaperone assembles in a tetradecameric ring creating a cavity that can be occupied by a 
protein molecule undergoing the folding reaction. There remain many open-ended 
questions pertaining to the molecular mechanism of the action of GroEL. For our 
purposes we assume that GroEL is a channel that funnels proteins from the unfolded state 
to the native state in any of the two predominant modes of its action (passive folding 
cage/active substrate interaction leading to folding). The second set of chaperones is the 
Hsp70 family, with DnaK as the E. coli member, which works with its associated co-
chaperones DnaJ and GrpE (Calloni et al., 2012; Kim et al., 2013). There is little direct 
evidence that DnaK directly facilitates the formation of the native state from the unfolded 
state, i.e. it does not directly affect the folding rate; rather DnaK seems to prevent 
transitions into off-pathway misfolded states and provide an escape route from such a 
misfolded state. This role contributes to an effective increase in the concentration of the 
folded native product (Clerico et al., 2015). Proteomic analysis has yielded a list of ~250 
proteins that can interact with GroEL, and of these 80 proteins in the E. coli proteome 
which are unable to fold without the assistance of the GroELS chaperone system (Kerner 
et al., 2005). Such proteins have been termed as class III or obligate GroEL substrates.  
Furthermore, a depletion of GroELS from cells results in the accumulation of client 
proteins on the DnaK chaperone (Kerner et al., 2005). These interesting observations lead 
us to investigate the how these two major chaperone systems work together to achieve 
folded protein in vivo. An interesting question arises from these observations: what are 
the biophysical properties of the obligate chaperone-dependent client proteins? 
		70 
Specifically, what are the biophysical folding/misfolding properties of such client 
proteins in terms of folding and unfolding rate and equilibrium constants, and how do 
these constants compare with one another for an obligatory chaperone client? 
Furthermore, can we estimate these properties from cellular experiments and observed 
dependence on chaperones? This would be useful information, particularly considering 
the fact that refolding these proteins in vitro without chaperone assistance is extremely 
challenging. These questions are all part of understanding how the biophysical properties 
of proteins interface with the proteostasis network inside the cell such that folding is 
optimized and deleterious consequences such as aggregation are avoided. 
 
3.2. What can we hypothesize about proteins that depend on chaperones in vivo? 
Kinetic competition is a central theme underlying protein folding inside the cell. Once a 
protein is synthesized, the intrinsic propensities to fold, misfold and aggregate will dictate 
the trajectory of that protein inside the cell. One class of the major factors that influences 
these trajectories are molecular chaperones and degradation enzymes (described above). 
Using a computational model (FoldEco) developed by our lab in collaboration with Evan 
Powers, we asked what types of proteins would be most aided by different classes of 
molecular chaperones (Powers et al., 2012)? In this calculation, a test dataset of 4000 
proteins of varying biophysical properties (within published limits) was created. In the 
modeling these proteins were synthesized at various synthesis speeds using the FoldEco 
program in the absence of any molecular chaperones. FoldEco tracks the time evolution 
of pools of protein in different states of the protein including native, misfolded and 
aggregated as well as chaperone-bound, and the program was used to generate the 
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concentration of protein that aggregated at the end of the experiment. In a second 
experiment with the same protein set, the molecular chaperones DnaK (the KJE system) 
and GroEL (the ELS system) were reintroduced individually, and the fate of the 
aggregated pool of proteins was similarly tracked. Based on these simulation 
experiments, it was inferred that at slower synthesis rates the presence of DnaK lowered 
the aggregation of those proteins that had a high propensity to misfold compared to the 
average misfolding tendency of the set of proteins tested. Specifically the proteins most 
helped by DnaK had a high km (misfolding rate constant). Similarly, the presence of 
GroEL seemed to have its greatest effect on those proteins that folded much more slowly 
than the average folding speed of the set of tested proteins. However, at faster synthesis 
rates, the roles of GroEL and DnaK were seemingly very similar, and slow folding 
proteins were aided by DnaK as well as GroEL, whereas proteins with a higher 
propensity to misfold were also helped by both chaperone systems. Another experiment 
from the same study, asked the question of how the presence of degradation machinery, 
specifically the Lon protease affected the folding of proteins. Up-regulation of Lon, as 
the study suggests and predicts had an impact on the total protein concentration, but had a 
stronger impact on the misfolded species as it accumulated (Figure 3.1). Taken together, 
these simulations suggest a synergistic action of the proteostasis components to shuttle 
substrates from the unfolded (U) state to the native state while simultaneously lowering 
the population of the protein that accumulates in the misfolded (M) state either by 
prevention of the formation of the M state or by its degradation. 
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Thus, we hypothesize that a protein that requires GroEL to fold successfully (a class III 
substrate as classified by Kerner et al. (2005)) (Kerner et al., 2005), is a slow folding 
protein, i.e. with a low kf (rate constant of folding). Based on how the protein aggregates, 
one can then determine what the misfolding and aggregation rate constants would be 
relative to the folding rate constants. Additionally, if one can introduce probes for the 
unfolded state (such as GroEL) or for the misfolded state (such as Lon) or perhaps both 
(such as DnaK) based on the hypotheses generated by the FoldEco simulations, one can 
start to dissect the folding behavior of an obligate chaperone client inside the cell. 
 
In experimental studies performed by Cho et al. (Cho et al., 2015) on studying the impact 
of the proteostasis network on protein folding inside E. coli the FoldEco model was 
useful to back calculate some of the biophysical parameters of the proteins in the study. 
And while that study was informative in terms of how chaperone systems can work 
together to benefit folding, it did not address the folding behavior of a naturally occurring 
protein that has co-evolved over millennia with cellular chaperones and to fold under 
their influence. 
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Figure 3.1 Hypotheses for chaperone functions based on computational modeling 
  
A. Based on the FoldEco simulation study with 4000 proteins with a distribution of 
folding, misfolding and aggregation rate constants, at slower synthesis rate proteins with 
high misfolding were prevented from aggregation by the KJE system, similarly slow 
folding proteins were helped by GroELS.  
 
B. At increased synthesis rate the effects of the GroELS and DnaK were seen on proteins 
with similar properties of folding and misfolding. Both GroEL and DnaK reduced the 
aggregation of those proteins with low folding rate constants and had a higher than 
average misfolding propensity. 
 
C. Lon has ability to suppress aggregates by reducing protein concentration. The 
concentration of protein reduced by lon depends on the presence of the other chaperones 
that can act to sequester the protein away from. Figure adapted from Powers et al (Powers 
et al., 2012). 
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3.3. Choosing an experimental system 
We chose to work in E. coli BL21(DE3) for experimental tractability and the fact that it 
lacks the Lon protease allowing us to study chaperone dependence in a background 
without proteolysis (which for FoldEco we assume is performed by Lon). In our lab, we 
have methods to upregulate individual chaperone components by mean of a plasmid 
provided in trans to the genetic copy of the chaperone or the degradation enzyme lon 
(BL21(DE3) lacks a functional Lon protease thus making it easier to determine the 
effects of varying concentrations of Lon on the substrate in the presence of other 
chaperones). Much of the power of FoldEco also comes from the biochemical 
investigations that have been carried out over the past several years on the chaperone 
systems of this organism. As there are only two major chaperone systems, GroEL and 
DnaK, we do not have to worry about redundant versions of the chaperone systems 
playing a major role in the folding of our test protein.  
 
For our test protein we chose a native E. coli protein S-adenosylmethionine synthase 
(gene name metK). MetK is an enzyme with a transferase function (E.C. 2.5.1.6) 
(UniProt, 2015). Specifically it catalyzes the formation of S-adenosyl methionine using 
ATP and Methionine as substrates. MetK is a cytosolic, soluble 384 amino acid protein 
with a monomeric molecular weight of ~42 kDa. MetK assembles into homotetramers as 
a final quarternary structure (Figure 3.2) (Komoto et al., 2004). MetK has been shown to 
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be a class III GroEL substrate. In in vitro refolding studies by the Hartl lab (Kerner et al., 
2005), MetK is unable to fold and function when introduced into refolding conditions in 
the absence of the GroELS system. Refolding in the presence of GroELS alone restores 
MetK activity to ~70% of native MetK whereas refolding in the presence of DnaKJE and 
GroELS restores up to 90% activity of the protein. Refolding in the presence of the KJE 
system alone, however, does not restore any measurable activity. These in vitro tests 
indicate that MetK obligatorily requires an interaction with GroEL to reach the native 
state. MetK on a pET 29b plasmid was kindly provided to us by the Hartl laboratory 
(Max Planck Institute, Martinsried Germany) and the proteostasis components were 
available on arabinose inducible pBAD plasmids that were provided from previous 
FoldEco studies conducted jointly with the Kelly/Powers laboratories (Cho et al., 2015; 
Kerner et al., 2005). 
 
Figure 3.2 Model test protein MetK 
 
A. The choice of test protein is MetK (PDB 1RG9), monomer and tetramer shown above. 
MetK is a homotetramer and GroEL catalyzes the folding of this protein. For our 
experimental consideration, we treat the species subject to proteostasis treatment to be the 
monomer. 
 
B. The above cartoon shows the reaction catalyzed by MetK. The enzyme is essential in 
E. coli and is responsible for the biosynthesis of S-Adenosyl methionine. 
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3.4. MetK – Equilibrium folding properties of MetK 
To understand the folding properties of MetK, i.e. the folding rate constant, unfolding 
rate constant, misfolding rate constant and the aggregation rate constant in the cellular 
context we need to first dissect the contribution of tetramerization to the folding fate of 
MetK. Tetramerization can be regarded as self-liganding mechanism for MetK as is seen 
in the case for transthyretin and other multimeric enzymes. To determine the 
tetramerization dissociation equilibrium constant, we performed equilibrium denaturation 
experiments with guanidine hydrochloride as a function of MetK concentration. MetK 
denaturation shows a three-state equilibrium unfolding curve and the midpoint of the first 
transition shows a concentration dependent sensitivity to guanidine induced denaturation, 
whereas the midpoint of the second transition is insensitive to MetK concentration at 
higher guanidine concentrations. This observation is consistent a dissociation of the 
tetramer at low guanidine concentrations causes while the denaturation of the monomer 
occurs at higher concentrations of the chaotrope. By performing guanidine denaturation 
experiments as a function of MetK concentration we were able to determine two 
equilibrium parameters for MetK. The first was the limiting tetramerization 
concentration. This was determined as the concentration of MetK at which the first 
transition was no longer seen in the guanidine denaturation experiment. The second 
parameter was the apparent unfolding equilibrium constant, which would theoretically be 
the ratio of the unfolding to folding rate constants. This number could serve as a guide to 
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help fit some of the MetK rate constants using FoldEco. From our experiments, the 
limiting tetramerization concentration was ~0.13 µM as at that concentration the first 
transition was not seen for MetK denaturation (Figure 3.3A). This suggests that even at 
low concentrations, MetK readily forms the tetramer and once it is in the tetrameric state, 
it can be assumed to be resistant to aggregation that would initiate as consequence of 
tetramer dissociation and unfolding (see chapter 2 for how ligands prevent aggregation). 
The second equilibrium constant we obtained was the apparent unfolding equilibrium 
constant which was 9 x 103, indicating that the monomer of MetK was stable as the 
folded species outnumbered the unfolded species by roughly 10000 molecules to 1 
(Figure 3.3B). It is important to note here that the unfolding equilibrium constant is an 
apparent constant, since the reaction is not reversible. Effectively, folding does not occur 
without GroEL assistance. 
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Figure 3.3 Equilibrium denaturation properties of MetK 
  
A. The family of curves depicts MetK denaturation over a range of concentrations (brown 
– 0.136, red – 0.272, green – 0.408, blue – 0.572 and pink – 1 µM concentration of 
tetrameric protein respectively). One can observe two transition points, one under 1M 
wher Cm changes with MetK concentration and 1 at approximately 2.5 M where Cm does 
not change. The first transition which represents tetramer dissociation disappears at 0.13 
uM thus allowing us to determine the equilibrium constant for tetramer dissociation.  
 
B. Denaturation of monomeric MetK. This set of points is derived from the full 
denaturation, this transition does not change with MetK concentration, The equilibrium 
unfolding constant for the monomer (Ku) was calculated to be – 9 x 103 .by fitting the data 
to the two-state equation to estimate folding free energy (Bolen and Santoro, 1988).  
 
C.  Model for equilibrium MetK unfolding. We propose a model for MetK denaturation 
where dissociation of the tetramer is the first step and it is limited by the concentration of 
MetK and the second step is the denaturation of the monomer. Monomer denaturation is 
shown irreversibly as the protein depends on GroEL to get to the folded state. 
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3.5. MetK overexpression and aggregation at “basal” proteostasis levels. 
To determine the nature of the competition between folding and aggregation, we 
overexpressed MetK in E. coli BL21(DE3) cells. We examined the folding fates of MetK 
by quantifying the total amount of MetK synthesized and then interrogating what fraction 
of the protein produced became insoluble after our synthesis time. It is important to note 
here that as there is no degradation component yet, MetK has two possible folding fates; 
either it folds correctly (with the help of GroEL) or it misfolds, self-associates and 
aggregates, which is to say it escapes any positive interaction with GroEL and has 
misinteractions with other MetK molecules. We use solubility or insolubility after 
expression as a readout after protein synthesis to determine where MetK partitioned after 
production. We assume that soluble MetK is well folded, but the soluble MetK could be a 
mixture of well folded, chaperone bound or a ligand bound (MetK binds ATP, 
methionine and the product S-adenosyl methionine) species, a partition that presently 
evades separation. However, the insoluble MetK is obtained from inclusion bodies, which 
contain the misfolded MetK that aggregates inside the cell after synthesis. Thus we use 
the aggregated fraction (Fagg or Fractionaggregated), defined as the ratio of the intensity of 
the aggregated fraction to the intensity of the total protein synthesized as our readout for 
the folding of MetK (see equations below). The intensity of the total and aggregated 
fraction was calculated after running the samples on a 12% SDS-PAGE gel and staining 
with Coomassie G-250 stain. Stained gels were imaged using the LI-COR system and 
were analyzed using the associated gel analysis software. 
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[MetK ]Total = [MetK ]sol +[MetK ]insol
Fractionaggregated =
[MetK ]insol
[MetK ]total
 
 
 
As mentioned earlier, the MetK gene was subcloned into a pET29b vector, with protein 
expression driven from an isopropyl β-D-1-thiogalactopyranoside 
 (IPTG) inducible T7 promoter. To investigate the folding-aggregation competition of 
MetK, we varied its concentrations inside the cell by titrating increasing amounts of 
IPTG (from 1 µM to 200 µM final concentrations) into cells grown to mid-log phase 
(OD600 ~ 0.6). By comparing total cell lysates to purified MetK standards, we were able 
to calculate the amount of MetK synthesized at each concentration of IPTG. We observed 
that the MetK concentration ranged from 170 µM to approximately 2000 µM over the 
range of IPTG concentrations we used. We also observed that protein concentration 
peaked at ~2000 µM and did not rise further with increase in concentration of IPTG 
(Figure 3.4A). The concentrations reported are MetK monomer concentrations and not 
the tetramer. For our experiments we assume that the monomer is the species acted upon 
by the cellular proteostasis network. We then calculated the concentrations of the 
chaperones DnaK and GroEL present at our growth conditions, again by comparison with 
standard purified amounts loaded on SDS-PAGE gels. The aggregated fraction of MetK 
was measured after harvesting cells at the end of the protein induction time, followed by 
cell lysis by sonication and separation of soluble and insoluble components by high-speed 
centrifugation. The aggregated fraction of MetK increased with an increase in the 
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concentration of MetK synthesized (not surprisingly, as aggregation is concentration 
dependent). The fraction aggregated (measured from 0 to 1) rose from an average of 0.2 
at an intracellular concentration of MetK of 170 µM MetK to an average of 0.45 at 
approximate [MetK] of 2000 µM (Figures 3.4 A, B). For these experiments performed at 
what we term “basal” levels (no chaperone overexpression), the concentrations of GroEL 
(as an active tetradecamer) and DnaK were calculated to be 130 and 70 µM on average 
Figures 3.8A, B see pages 120-123).  
 
 
Figure 3.4 Synthesis and aggregation of MetK at basal chaperone conditions 
 
A. The above figure shows the concentration of MetK synthesized at varying IPTG levels 
under “basal” levels of chaperones. MetK levels rise with IPTG concentration until 
200uM, then plateau. The concentration in cell measured by comparison with purified 
standards.  
 
B.  Fagg of MetK as a function of concentration. MetK Fagg increases with increase in 
concentration from 0.25 to 0.47 under “basal” chaperone conditions. Due to a limitation 
of MetK synthesized the aggregated fraction does not rise further. 
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Our observations with MetK folding/aggregation at these basal chaperone conditions 
allow us to draw some important conclusions. First, even at nearly stoichiometric 
amounts of MetK to GroEL (at low concentrations), MetK aggregates inside the cell. 
This suggests that the intrinsic propensity of MetK to aggregate is higher than the 
association rate with GroEL (and perhaps even the equilibrium association with GroEL). 
Thus if we were to now begin to compare the folding and misfolding rate constants for 
MetK (which we suggest are the major drivers for the distribution of MetK), at a first 
approximation the ratio of the misfolding/aggregation rate constants to the folding rate 
constant is larger than 1 (As km, kagg > kf). The next set of experiments involves the 
overexpression of either the GroELS system or the DnaKJE system or the Lon protease to 
determine how the fluxes between folding and aggregation change when you have 
mechanisms to selectively target one or more states. Knowledge of its folding outcomes 
in the presence of lon and the DnaKJE system would refine our understanding how the 
other biophysical parameters – misfolding and aggregation would be compared to the 
folding parameters – we plan to bolster our experimental findings with computational 
modeling to achieve a more quantitative understanding of the system. Furthermore, these 
experimental readouts can then be used as inputs for FoldEco simulations to predict what 
the biophysical parameters for MetK might be inside the cell. 
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3.6. Effect of GroELS titration on MetK aggregation  
(These experiments were performed in collaboration with Ha Van Dang – Mount 
Holyoke College)   
Since GroEL serves as a conduit that funnels MetK from the unfolded state to the folded 
state, we hypothesized that increasing the concentration of GroELS would enhance the 
efficiency of MetK folding and lead to a diminution of the aggregated MetK population . 
We co-transformed E. coli BL21(DE3) cells with the MetK plasmid and a GroELS 
plasmid, with the expression of GroELS driven by an arabinose inducible promoter and 
that of MetK by an IPTG inducible T7 promoter. GroELS was titrated to varying 
concentrations using concentrations of arabinose from 0.002 to 0.2% (w/v final 
concentration) (Figure 3.8A). The range of [arabinose] used allowed us to test [GroEL] 
from the basal level of ~130 µM to as high as approximately 1600 µM. For these 
experiments, we first grew the co-transformed cells to an OD600 of 0.3 at which point we 
induced GroELS with the desired amount of arabinose. After 1 generation of growth at 
OD600 of 0.6 we induced MetK with varying IPTG concentrations. Determination of total 
MetK and fraction MetK aggregated was performed similarly. 
 
We made two major observations regarding MetK synthesis and aggregation with the 
GroEL titration experiment. First, as GroELS intracellular concentrations increased, the 
aggregation of MetK decreased. This result is not surprising as MetK is an obligate 
GroEL substrate. It is important to note here that at no point is the aggregation of MetK 
completely abolished. There appears to be a limit of about 0.15 fraction MetK aggregated 
regardless of the concentration of GroELS (Figure 3.5A). At basal concentrations of 
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GroELS (~130 µM), MetK synthesized at about 2000 µM has an average fraction 
aggregated of ~0.45. However, at the same concentration of MetK, the higher level of 
GroELS (~1600 µM) reduces the fraction aggregated to ~0.2. The observation that MetK 
aggregation is not entirely abolished even at high GroELS levels (MetK ~ 170 µM, 
GroEL ~ 1600 µM) allows us to suggest that the intrinsic misfolding rate of MetK (km) is 
larger than the association rate constant between MetK and GroEL (and thus the rate 
constant of GroEL mediated folding) (Figure 3.5C). This lower limit on aggregation is 
similar to the one observed for dDHFR observed in Chapter 2 and also suggests a 
chaperoning limit akin to the limit of the small molecule ligand which depends on the 
intrinsic ratio of the folding to aggregation rate constants (kf/kagg) 
 
The second observation was the fluctuation of MetK concentration at high levels of 
expression of GroELS. While the concentrations of MetK remained relatively unchanged 
at higher levels of MetK induction (in the presence of all concentrations of GroEL 
induced), we observed a reduction of the concentration of MetK synthesized at lower 
levels of induction (at lower IPTG concentrations). Generally we observed a reduction in 
MetK synthesis at low levels of IPTG (particularly 5 and 10 µM, which under basal 
conditions yields three-fold more MetK) and high levels of arabinose (at 0.02 and 0.2% 
w/v where we achieve a GroEL concentration roughly 9 to 12 times of our basal level) 
(Figure 3.5B). This observation indicates that there is a competition for protein synthesis 
machinery, and that though we used orthogonal promoters to induce MetK and GroEL, 
the protein synthesis outcome depends on the partitioning of the protein production 
resources inside the cell. Interestingly, although not pursued, is the debunking of the 
		92 
notion that an IPTG inducible T7 promoter essentially overrides the protein synthesis 
system preventing the translation of other proteins. This example of MetK – GroEL 
(recollect that GroEL is induced with arabinose before MetK induction with IPTG) is a 
good demonstration that the T7 driven expression can be affected by the production of 
protein driven by an alternative promoter. 
 
Figure 3.5 Impact of GroEL expression on MetK synthesis and aggregation.  
 
A. The SDS PAGE gels show that higher GroEL concentrations lower the aggregation of 
MetK at equivalent MetK concentrations (synthesized with 50µM IPTG). The Fagg never 
reaches zero even at sub-stoichiometric amounts of MetK compared to GroEL indicating 
a propensity to aggregate faster than association with GroEL. 
 
B. GroEL induction at high levels causes diminution of MetK levels when MetK is 
induced with low concentrations of ITPG likely due to competition for protein synthesis 
machinery. C – trends observed for MetK aggregation as a function of GroEL and MetK 
concentrations at the GroEL concentration Data and figures courtesy Ha Van Dang. 
 
C. The chart shows the concentration of MetK and the fraction aggregated at different 
average GroEL levels (top left corner – indicated by colours from red to blue). MetK 
aggregation generally reduces with increasing GroEL concentrations, however there is no 
concentration of GroEL at which MetK aggregation is entirely abolished. The error bars 
represent an SEM of three experiments. 
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3.7. Effect of DnaKJE on MetK aggregation  
From the GroELS titration and the MetK aggregation at stoichiometric and higher 
amounts of GroELS, it is clear that MetK has an intrinsic tendency to populate an off-
pathway aggregation-prone misfolded state faster than it can encounter GroEL. This 
indicates that MetK populates the unfolded state (the precursor of all states), which 
partitions into the misfolded state (the same one that arises from the unfolded progenitor 
pool) and the state that binds GroEL. Based on the hypothesis presented earlier, the 
presence of DnaK should aid in the correct folding (and thus lower the aggregation) of 
proteins with a higher propensity to misfold. Experimental data from the Hartl lab 
(Calloni et al., 2012) also suggests that GroEL substrates accumulate on DnaK upon 
depletion of GroELS inside the cell. This too indicates a synergistic tendency of DnaK to 
bind unfolded or misfolded proteins and prevent aggregation. Similar to the above 
experiments with GroELS, we co-transformed E. coli BL21(DE3) cells with the MetK 
plasmid and the plasmid containing genes for DnaK, DnaJ and GrpE. Also similar to 
GroELS, the expression of the components of the KJE system was driven by arabinose. 
The KJE components and MetK were induced by IPTG, similar to the protocol used for 
the GroELS and MetK experiments.  
 
Mimicking the observation in the GroEL induction experiments, the biosynthesis of 
MetK showed a diminution at high concentrations of arabinose and low concentrations of 
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IPTG, although the reduction in MetK synthesis was not as drastic as the one observed 
with the GroEL experiment. By varying the concentration of arabinose (from 0.002 to 
0.2% w/v final concentration), we could increase the concentration of DnaK from ~70 
µM at basal (no addition of arabinose) level to ~700 µM (approximately 10-fold higher) 
at the highest concentration of arabinose (0.2% w/v) used (Figure 3.8B). Over the range 
of DnaK concentrations we tested, we observed a general decrease in the fraction of 
MetK aggregated across nearly all MetK concentrations (Figure 3.6C). The decrease in 
MetK aggregation also scaled with the increase in the concentration of DnaK, i.e. as we 
synthesized more DnaK inside the cell, we observed a reduction in the aggregated 
fraction at almost all concentrations of MetK produced, and this aggregated fraction 
further diminished as DnaK concentrations rose (compare Figure 3.6A and B, compare 
across concentrations of MetK and DnaK where DnaK concentrations increase from Blue 
to Red and the MetK concentrations are represented on the X axis). The aggregated 
fraction at lower levels of expression of MetK (170 µM) reduced from ~0.25 to ~0.1 at 
the highest concentration of DnaK produced inside the cell. Similarly, the fraction MetK 
aggregated when approximately 1500 µM was synthesized also reduced from an average 
of 0.35 to 0.15. It was only at the highest levels of MetK synthesis that the aggregated 
fraction of MetK was not reduced to a large extent (last concentration point shown in 
Figure 3.6B, all colors). What does this tell us about the impact of DnaK on the folding of 
MetK? First, as we know that MetK folds in a GroEL-dependent manner, it is not the 
overexpression of DnaK that aids the folding reaction directly. However, given enough 
DnaK, the cellular pools of GroELS (which did not appear to increase during these 
experiments) become sufficient to achieve a high proportion of folded MetK. This 
		97 
suggests co-operation between the DnaK and GroELS chaperones. It appears that DnaK 
can form a complex with MetK to protect it from aggregation, and then that DnaK 
releases MetK in a form that is ushered by GroEL to the folded state. It should also be 
noted that at no concentration of DnaK was the aggregation of MetK (at any 
concentration) entirely abolished. All these observations are consistent with the 
hypothesis that proteins with a high propensity to misfold are aided by the KJE system to 
avoid aggregated states, and importantly this role of DnaK can work in concert with the 
action of the GroELS system for proteins that are obligate GroEL substrates.  
 
Figure 3.6 Impact of DnaKJE on the folding and aggregation of MetK.  
 
A. DnaK at high levels ~ 650 uM strongly inhibits MetK aggregation as seen by the low 
intensity aggregation bands at nearly all MetK concentrations on the SDS PAGE gel.  
 
B. Similar to GroEL, as DnaK concentration increases (top right corner shows the 
average DnaK concentration at the levels of MetK synthesized) the MetK aggregate 
fraction reduces, yet never going to 0. DnaK helps prevent aggregation and allows what 
little GroEL (estimated at 130 µM average) is present inside the cell to successfully fold a 
large concentration of MetK. 
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3.8. Effect of Lon titration on MetK aggregation in basal levels of KJE and GroELS 
In addition to the folding limb of the proteostasis network, the other component of 
protein quality control that keeps aggregation under check is the degradation machinery. 
For proteostasis in E. coli the degradation machinery proposed to do this function is the 
Lon protease. Experimental and modeling results suggest that while Lon decreases the 
total concentration of a protein, this also causes a reduction in the amount of protein that 
aggregates. There are two species that are believed to be degraded by the Lon protease 
are the unfolded and misfolded state (Gur and Sauer, 2008; Gur et al., 2012; Powers et 
al., 2012). Modeling of the fraction degraded and fraction aggregated data of the model 
proteins used by Cho et al. (Cho et al., 2015) suggests that Lon targets either the unfolded 
state or the misfolded state depending on how much the protein substrate intrinsically 
populates the off-pathway misfolded state. For the DHFR mutant used in that study, the 
effect of the Lon protease was on the unfolded state whereas the effect for the mutant 
Cellular Retinoic Acid Binding Protein I (CRABPI) Y133S was on the misfolded state. 
BL21(DE3) has no functional Lon protease. Up to now, all our investigations were in the 
absence of any degradation caused by the Lon protease. Thus, re-introduction of Lon at 
varying concentrations allowed us to directly test the effect of the protease in the 
background of basal GroEL and DnaK conditions. Similar to the protocol used with the 
GroELS and DnaKJE systems, the E. coli Lon gene was cloned into a plasmid where its 
expression is controlled by arabinose. The experiments with Lon induction and protein 
partition were performed similarly to the GroELS and DnaKJE experiments. 
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Lon concentrations increased with increasing arabinose concentrations added to the cells. 
The concentrations rose from ~3 µM hexameric (the active state is a hexamer) Lon at an 
arabinose concentration of 0.002% final w/v to an average of 23 µM Lon at the highest 
concentration (0.2% w/v final) used (Figure 3.8C). Over the range of Lon concentrations 
tested, MetK concentrations at all levels of IPTG were depleted relative to that in the 
absence of Lon (Figures 3.7A, B). For example, the final concentration of MetK for the 
same addition of IPTG was reduced by half when Lon was present at 23 µM (compare 
blue and red points in Figure 3.7C). Furthermore, the aggregated fraction was also 
diminished at higher Lon concentrations. This is not a novel observation as a reduction in 
protein concentration diminishes the concentration of the aggregation prone species. 
However, we clearly observed that at nearly equal concentrations of MetK (see data 
points between 600 and 1100 µM MetK), an increase in Lon concentration reduces a 
larger amount of the aggregated protein (Figure 3.7C). This is indicative of a mechanism 
where Lon facilitates the clearance of a species en route to aggregation. For MetK, it 
appears that the presence of Lon has an impact on the misfolded species as it selectively 
reduces the aggregated fraction within the total protein population. This observation is 
consistent with the hypothesis that Lon degrades off-pathway misfolded proteins (Powers 
et al., 2012). Also consistent with the impact on Lon in BL21(DE3) cells, cells expressing 
a high concentration of Lon also grew more slowly than cells with little or no Lon 
present. This is likely due to the degradation of the yoeB antitoxin which is the cognate 
antitoxin in the yefM – yoeB toxin – antitoxin pair, which has been implicated in biofilm 
		102 
formation and regulation of its own gene products via transcriptional attenuation 
(Christensen et al., 2004).  
 
Figure 3.7 Impact of lon on MetK synthesis and aggregation. 
 
A. The SDS PAGE gesl shows the impact lon at medium levels ~ 17 uM. This 
concentration of lon reduces concentration of MetK synthesized at the same 
concentration of IPTG added under the basal conditions (compare with Figure 3.4). It 
also reduces the aggregated fraction, not surprising as total levels of MetK are lowered.  
 
B.  Increase in lon concentrations (from Blue to Red, top right corner shows average 
values) lowers MetK synthesized proportionally with the lon synthesized. Similar 
concentrations of MetK between (700 – 1100 uM MetK) show altered aggregated 
fraction and higher the lon levels, lower the Fagg at these concentrations. This indicates 
that lon degrades an aggregation prone, off-pathway misfolded state. 
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Figure 3.8 Concentrations of chaperones produced as a function of arabinose 
concentrations.  
 
A. GroEL synthesized during the GroELS titration experiments is measured by 
comparison against purified GroEL. 
 
B. Similarly DnaK synthesized at the various DnaKJE titration experiments is measured 
by comparison with purified proteins. 
 
C. Lon concentrations are also measured by comparison with purified standards. Purified 
GroEL, DnaK and lon were gifts from Ivan Budyak, Joseph Tilitsky and Rilee Zeinert 
respectively. 	  
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3.9. Modeling the data with FoldEco  
(The mathematical modeling was performed by Evan Powers) 
To understand the folding behavior of MetK inside the cell, we used FoldEco to fit our 
experimental data. The major parameters in FoldEco that can be manipulated are the 
equilibrium constants and kinetic rate constants for the folding, misfolding and 
aggregation reactions. The FoldEco simulation was performed iteratively to match the 
experimental dataset. The best fit between the FoldEco simulation and the experimental 
data showed a root mean squared deviation of 0.13 and allowed us to infer three 
important conclusions. The first, is that the ratio misfolding rate constant to the folding 
rate constant (km/kf) is 2 which is in good agreement with our hypothesis from section 3.5 
where we state km is larger than kf. Specifically the FoldEco fitting allows us to 
approximate the values of km and kf to 0.02/s-1 and 0.01/s-1 respectively. These values are 
also in good accord with the predictions made by FoldEco about proteins that rely on the 
GroELS system (and MetK is an obligate substrate). The second conclusion is that 
aggregation is almost instantaneous after accumulation of the misfolded state suggesting 
a low life time for this off-pathway state. Third, the fit also does not converge well on the 
equilibrium constants again suggesting that the partitioning of MetK inside the cell is 
under kinetic control rather than thermodynamic control. In Figure 3.9 we see a general 
schematic for the kinetic partitioning for MetK and using this model (that is essentially 
how FoldEco describes the kinetic partitioning of proteins) we can now being to see how 
the folding and misfolding reactions compete with each other in the presence of 
chaperones and how chaperones change the folding outcome even when the misfolding 
rate constant is larger than the folding rate constant. 
		109 
 
Figure 3.9 The kinetic partitioning of MetK upon synthesis in E. coli 
 
The figure below shows the general kinetic partitioning scheme for MetK. S, U, N, D, A 
and M represent the synthesized, unfolded, native, degraded, aggregated and misfolded 
populations of MetK. The rate constants for the individual reactions is denoted by kreaction. 
Folded MetK is represented as a monomer (Nmono) or a tetramer (Ntetramer). GroEL 
catalyzes the transition from U to N. DnaK is shown to interact with either the U or the M 
state whereas lon is shown to degrade either the U or M state. The aggregates are shown 
as inclusion bodies which is how proteins aggregate in E. coli. 
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3.10. Conclusions  
Our experiments provide insight into the species populated by MetK upon synthesis in E. 
coli. Consistent with hypotheses generated by FoldEco, MetK is a slow folding protein 
that tends to populate the off-pathway misfolded state with a larger than average (with 
respect to the average properties of the 4000 test proteins used in the computational 
study) (Powers et al., 2012) propensity. This misfolded population is hypothetically a 
target for the Lon protease, and our results support this hypothesis in that we observed a 
greater diminution in the fraction aggregated than the total protein at similar 
concentrations of MetK as Lon concentration increased. The propensity of MetK to 
aggregate even at larger than stoichiometric concentrations of both GroEL and DnaK 
indicates that MetK has an intrinsic aggregation rate faster than a GroEL facilitated (as 
without GroEL the rate is not readily observable in reasonable time scales) folding rate. 
Furthermore, we have inferred a chaperone cooperation wherein DnaK is able to prevent 
the aggregation of MetK and subsequently co-ordinate with GroEL to ensure the 
successful folding of a large population of the protein.  
 
While the folding of MetK is stringently dependent on GroEL in E. coli, it is interesting 
to note that organisms lacking GroEL such as Mycoplasma synoviae have MetK 
homologs (Georgescauld et al., 2014). The M. synoviae MetK shares approximately 47% 
percent sequence identity with the E. coli MetK. On imposing the similar residues on to 
the structure of the E. coli MetK, we observed that the similar residues were concentrated 
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at the interface of the MetK dimer (Figure 3.10). This provides a hypothesis that the 
assembly of MetK might be conserved evolutionarily, whereas the folding of the 
monomeric protein has co-evolved with the organismal proteostasis network (or lack 
thereof). 
 
Figure 3.10 MetK assembly might be independent of monomer folding. 
 
A. The image shows the dimer of E. coli MetK (PDB 1RG9) with one chain shown in 
spheres and the other as a cartoon. Comparing the sequences of homologous MetK, one 
from E. coli and another from an organism that lacks GroEL (M. synoviae), it is apparent 
that identical residues (coloured red) are clustered in the dimer interface whereas non-
identical residues (coloured green) are distal to the dimer interface. This figure looks at 
the dimer interface through one of the monomers (blue cartoon). 
 
B. This cartoon shows the MetK dimer interface from the side where the residues 
identical between E. coli and M. synoviae are easier to visualize. This conservation 
pattern can be used to hypothesize that MetK assembly might be evolutionary conserved 
but the folding of the monomer has co-evolved with the chaperone in the case of E. coli. 
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Lastly, as seen in the section of how DnaKJE help out MetK under limiting 
concentrations of GroEL, it has not escaped our attention that in this scenario, DnaK is 
able to compensate for the action of GroEL at most concentrations of expressed MetK. 
There could be two ways DnaK could exert its effect, the first being serving as a holding 
point for freshly synthesized MetK and keeping it from aggregation. In this scenario, the 
synthesized MetK would partition simultaneously to both DnaK and GroEL but as the 
concentration of MetK exceeds the concentration of GroEL the remainder of the protein 
would partition to the excess DnaK and finally the protein population that escapes both 
chaperone systems will aggregate. In this scenario, DnaK would hold on to the MetK 
polypeptide and release it in a manner capable of being acted upon by GroELS. The 
release of MetK and the processing by GroEL (which is necessary for MetK folding) 
appears to have some stoichiometric balance at lower levels of MetK as the limiting 
GroEL is able to handle that protein load in the presence of high concentrations of DnaK. 
The second model invokes the possibility that DnaK sequesters other GroEL client 
proteins and thus increases the capacity of GroEL to accommodate larger concentrations 
of the synthesized MetK. However, this model may not hold as most of the cellular 
protein synthesis machinery is occupied for the synthesis of the chaperone components 
(induced by arabinose) or for the synthesis of MetK (under IPTG control). Thus most of 
the protein synthesized will likely be MetK and thus reduces the chances (essentially 
outcompetes) of any other protein substrate to be bound by DnaK. 
 
3.11. Materials and methods 
 
• Cloning, expression and cell culture: 
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The MetK gene on a subcloned into a pET29b+ vector (Kanamycinr, IPTG inducible) 
was a gift from the Hartl laboratory (Max Planck Institute, Martinsried Germany). 
DNAKJE and lon genes were subcloned into the pBAD33 vector (Chloramphenicolr, 
arabinose inducible) and were the same as the constructs used in Cho et al. (FoldEco 
2015). Similarly the pGro7 was also the same construct used in Cho et al. with GroELS 
synthesis driven by arabinose. The chaperone plasmids were a gift from the Kelly 
laboratory (The Scripps Research Institute, La Jolla USA). 
BL21(DE3) E. coli cells (Invitrogen) were transformed with either the MetK or the MetK 
and one of any three of the chaperone plasmids mentioned above. The cells were plated 
on Luria Bertani (LB) agar containing Kanamycin and Chloramphenicol at a final 
concentration of 50 µg/ml and 34 µg/ml respectively. Cultures for the induction and 
partition experiments were started from overnight cultures initiated from a single colony 
of the transformed E. coli. For induction of proteins, the transformed cells were grown in 
LB medium at 37 o C until they reached an OD600 of 0.3 at which point the chaperone 
components were induced with the desired concentration of arabinose (range between 
0.002% and 0.2% w/v final concentration). Cells were then allowed to grow till an OD600 
of 0.6 (after ~30 minutes) at which point MetK was induced using a desired 
concentration of IPTG (range between 1 and 1500 µM final concentration). Cells were 
harvested by centrifugation at 4000 x g for 2 minutes after 1.5 hours of MetK induction 
after normalizing OD600 to 1 across samples.  
 
• Partition experiments and concentration measurement 
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Harvested cells were resuspended in 20mM Tris at pH 7.4 and were lysed using a 
sonicator. Sonicated cells were then centrifuged at 18,000 x g for 30 minutes to separate 
the soluble and insoluble components. The total (unlysed), the supernatant and the 
insoluble component (after resuspension in equal volume buffer prior to cell lysis) were 
then run on 12% SDS PAGE gels. The gels were stained with coomassie brilliant blue G-
250 dye and scanned on the LICOR gel documentation system after destaining. 
Quantification of the gel band intensity was carried out using the Odessy 4.0 software 
associated with the LICOR. To measure concentration of protein, known concentrations 
of purified protein (MetK, GroEL, DnaK or lon) were loaded on the same gels as the 
unknown sample. Comparison of the unknown to the standard curve generated from the 
purified protein yielded the concentration of protein (µG) present in the sample loaded on 
the gel. By accounting for the number of cells used for the experiment we estimated the 
cytosolic volume (Volkmer and Heinemann, 2011) and used that to measure the 
concentration (µM) of the protein inside the cell. Purified chaperone components GroEL, 
DnaK and Lon were kindly provided by Ivan Budyak, Joseph Tilitsky and Rilee Zeinert 
respectively. 
 
• Purification of MetK 
Cell growth and protein induction. 
MetK (pET 29b) was transformed into E. coli BL21(DE3) cells and a single colony was 
used to start an overnight culture. 1.5% of the overnight culture was used to start a fresh 1 
L LB + Kanamycin (final 50ug/ml) culture. The 1 L culture was grown to OD 600 of 0.6 
at which point it was induced with a final IPTG concentration of 0.2mM for 4-5 hours. 
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All growth and induction was done at 37 o C. Cells were harvested by centrifugation at 
4000 x g and resuspended in 20mM HEPES pH7.4 and flash frozen with liquid N2 until 
further use. 
 
• Cell lysis. 
Frozen cells were thawed under running cold water until completely thawed and then 
were lysed using the microfluidizer. After being microfluidized, the lysed cells were 
centrifuged at 20,000 rpm for 30 minutes and the insoluble fraction was discarded. The 
soluble fraction was processed further.  
 
• Ammonium Sulphate precipitation. 
The first step was to perform an ammonium sulphate precipitation of the protein and or 
contaminants. Solid ammonium sulphate was gradually added to the supernatant after cell 
lysis in 10% increments with slow stirring in 10 minute intervals. At 60% ammonium 
sulphate, the protein (soluble MetK) was mostly in the precipitate.  
  
The 60% ammonium sulphate precipitate was resuspended in 20mM HEPES at pH 7.4 
and dialyzed against 20mM HEPES at pH 7.4 to remove as much ammonium Sulphate as 
possible before further treatment. 
 
 
• Hydroxyapatite column chromatography. 
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The dialysate from the ammonium Sulphate precipitation was loaded a pre-equilibrated 
hydroxyapatite column (pre equilibrated with 10mM Sodium Phosphate monobasic-
dibasic buffer at pH 6.8. MetK binds both ATP and L-met and hydroxyapatite is a 
chemical mimic of ATP. The protein was loaded on the column and washed with 20mM 
sodium phosphate (monobasic - dibasic component buffer at pH 6.8) and eluted with a 
gradient ranging from 20mM to 300mM of the same buffer.  
 
MetK eluted in the wash, which was at low concentration of sodium phosphate and the 
impurities eluted at higher concentrations of the elution buffer. The sample was then 
dialyzed against 20mM Tris pH 7.4 and flash frozen and stored at -80 o C till further use. 
The concentration was determined by sending out pure protein for amino acid analysis at 
the Texas A and M university protein chemistry laboratory 
 
• Equilibrium denaturation experiments 
MetK at fixed concentration was diluted into a range of guanidine hydrochloride 
concentration and incubated over 12 hours at 37 o C to ensure unfolding. The unfolding 
of MetK as a function of guanidine hydrochloride was followed by collecting tryptophan 
emission spectra between 320 and 380 nm after excitation at 295 nm. Plotting the 
maximum wavelength as a function of guanidine chloride calculation yielded a three state 
equilibrium denaturation curve. Repeating the experiments over a range of MetK 
concentrations revealed the first transition sensitive to guanidine concentration and the 
second transition somewhat insensitive to MetK concentration. Fitting the second 
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transition to a two state equation yielded an apparent thermodynamic stability for the 
MetK monomer (Pace 1986).  
 
 
Data for MetK concentration, fraction aggregated and concentration of chaperones at 
various IPTG and arabinose concentrations is listed in the appendix section of the 
document.  
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CHAPTER 4 
MUTUALLY EXCLUSIVE FOLDING – SENSORS FOR PROTEIN 
STABILITY 
 
This chapter investigates how we can utilize a fusion protein system that relies on ligand 
binding to test the thermodynamic stability of a protein of choice inside the cell. This 
study attempts to bring together the concept of how ligand binding (explored in Chapter 
2) can be potentially harnessed to alter the stability of a protein connected distally to the 
ligand binding protein (the mutually exclusive folding model – discussed below). The 
work in this chapter was performed in collaboration with Beena Krishnan and Alexandra 
Walls. 
 
4.1. The mutually exclusive folding principle and the suitable choice of host protein 
In order to determine the thermodynamic stability of a protein inside the cell we have 
attempted to construct a mutually exclusive folding (MEF) system consisting of a host 
and test protein of our choice (see Figure 4.1) designed originally by Stewart Loh (Cutler 
and Loh, 2007; Cutler et al., 2009; Radley et al., 2003). The MEF system works on the 
basis that the coupling of the two proteins is architecturally incompatible. The differences 
in distance between the site of insertion on the host and the N to C distance of the test 
protein result in folding tug-of-war where both domains attempt to reach their individual 
native states. However a native state can only be achieved by one domain at the energetic 
cost of unfolding the other domain. Thus the ‘winner’ of this folding tug-of-war would be 
the protein with larger equilibrium stability (Figure 4.1A) (Cutler and Loh, 2007). 
		121 
Furthermore such MEF systems can act as molecular switches where a change in 
conditions can alter the folding equilibrium, thus selectively unfolding one of the two 
proteins (Radley et al., 2003). The choice of change in condition we desire to exploit is 
the stability imparted by the binding of a high-affinity ligand. Thus in our MEF scenario, 
the stability of the test protein is poised between the stability of the apo-host protein and 
the holo-host protein. Hypothetically, titration of the ligand would shift the population of 
the host protein from apo to the holo state, thus increasing the stability of the host protein 
relative to the test protein causing the test protein to unfold as a function of the 
concentration of the ligand added (Figure 4.4 pages 157-158). 
 
Figure 4.1 General design for a MEF system 
  
A. The cartoon shows the simple design for a mutually exclusive folding construct with 
two proteins, a host and a test. N-C termini of test (red arrows) are inserted into the host 
at a surface loop causing architectural mismatch and setting up a folding tug-of-war.  
 
B.  One of our MEF constructs has DHFR as the host protein and Ubiquitin as the test 
protein. Ubiquitin with its N-C distance of 37 Å is inserted into the DHFR surface loop 
(between 106 – 107) with a distance of 6.7 Å. With this distance incompatibility, DHFR 
and ubiquitin are now competing with each other to fold and the winner in this case will 
be ubiquitin as it has the larger thermodynamic stability. 
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4.2 Modified DHFR as a host protein 
For the choice of host protein we have selected DHFR modified at the same surface loop 
(between residues (106-107). This loop has also been manipulated in murine DHFR in a 
fragment based recombination assay (Remy et al., 2007). It has been previously shown 
that the DHFR fragmented at this loop can complement and can bind ligand (the two 
fragments re-constitute the structure) (Remy et al., 2007). DHFR was a feasible choice 
for the following reasons. First, the protein, while aggregation prone in vivo can be easily 
refolded from inclusion bodies suggesting that if we can control the folding/aggregation 
competition, we an obtain higher amounts of soluble protein inside the cell. Second, we 
have characterized the folding stability of this protein in vitro  at 37 o C (Chapter 2), and 
the low stability value of 0.5 kcal/mol at 37 oC is desirable as a stability value to be at the 
lower extreme of our MEF set up (the apo-test protein). Third, we know that the modified 
DHFR is capable of binding the high affinity ligand trimethoprim (TMP) with nanomolar 
affinity. A dissociation equilibrium constant in the range of 10-9 M imparts a stability 
enhancement of approximately 12 kcal/mol (we can calculate this by using the formula 
ΔG = -RTlnKd, where R is the gas constant, T the absolute temperature and Kd is the 
equilibrium dissociation constant). Lastly, the ligand trimethoprim is highly specific for 
DHFR and thus unlikely to interact with other proteins inside the cell, thus making the 
system specifically tunable inside the complex environment of the cell. These four 
properties allow us to consider DHFR as suitable host protein. Figure 4.1b shows an 
example of a MEF construct where DHFR is the host protein and Ubiquitin is the test 
protein inserted into the surface loop by its N and C termini. The distance incompatibility 
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between the two proteins at the point of insertion sets up a folding tug-of-war, which is 
the principle of the MEF design. 
 
Furthermore, we tested the thermodynamic stability of the modified DHFR to determine 
how much impact modifying the surface loop would have on the stability of this protein. 
While we know that the protein is destabilized by approximately 3 kcal/mol at 37 oC 
compared to wild type, this is only for one type of modification. To test the impact of 
altering the loop length, we tested the stability of wildtype DHFR and compared to it the 
stability of the gly-gly inserted variant and a variant with a (gly-gly-gly-ser)x2 
(GGGS2)variant inserted in the same position. The idea behind expanding the loop was to 
ask whether insertion of larger fragments would increasingly impact the already 
perturbed stability of DHFR (Figure 4.2A, B, C). The increase in loop length was 
hypothesized to minimally perturb stability, as it had no inherent structure, yet had an 
entropic component that could affect stability. This would not be the case when a folded 
domain would be inserted into the surface loop of DHFR (which would then be offset by 
ligand binding DHFR – as designed in the MEF system). We tested the thermodynamic 
stability of wildtype, GG and GGGS2 at 25 oC using urea denaturation experiments. The 
stability of wildtype DHFR was calculated to be about 6.4 kcal/mol which is in good 
agreement with the published value of 6.15 kcal/mol (Ionescu et al., 2000). The stability 
of the GG and the GGGS2 variants was estimated to be 3.4 and 3.1 kcal/mol respectively 
suggesting an appreciable reduction in stability compared to wildtype, but not when 
compared to each other. These values of stabilities agree with our hypothesis that while 
expansion of the loop with gly-gly perturbs stability significantly, further increasing the 
		125 
loop length does not further perturb stability drastically. These experiments suggest a 
certain baseline to which DHFR would be destabilized as the host protein in the MEF 
constructs. 
 
Figure 4.2 Equilibrium stability of DHFR constructs with modified surface loops  
 
A. Thermodynamic stability of wildtype DHFR at 25 0C is estimated to 6.4 kcal/mol.  
B. The insertion of gly-gly residues at the surface loop reduces stability to approximately 
3.4 kcal/mol.  
 
C. Increasing the loop length with a (gly-gly-gly-ser)x2 causes no drastic alteration of 
stability compared to the original loss of stability. In all panels the family of curves 
shows the fluorescence spectra recorded between 320 and 380 nm after excitation of 
tryptophan residues at 295 nm. The fluorescence at 344 nm is shown next to the family of 
curves showing an equilibrium two state denaturation. 
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4.2. The choice of reporter on the folded/unfolded state of the host or test protein.  
In collaboration with Beena Krishnan and Alexandra Walls 
In order to determine the status of the host or the test protein in our MEF system, we need 
a signal which reports on the folded or the unfolded status of the either the host or the test 
protein. We seek to build upon the existing fluorescence based methods to detect the 
folded state of a protein. Previous attempts to measure the folded populations inside cells 
have involved the use of the fluorophore Fluorescein Arsenical Hairpin binder (FlAsH) 
binding to either a contiguous or a split tetra-cysteine motif present within the protein of 
interest (Ignatova and Gierasch, 2004; Ignatova et al., 2007; Krishnan and Gierasch, 
2008). Here we design a third generation of tetra-cysteine motif, where the cysteine 
residues are inaccessible to the FlAsH fluorophore when the test protein is folded, but 
upon being unfolded, are solvent exposed, and thus capable of binding the FlAsH 
fluorophore. The quantum yield of FlAsH dramatically increases upon binding the tetra-
cysteine motif and the signal can easily be differentiated from unbound FlAsH. 
 
We chose to work with E. coli DHFR (our host protein), so that the ligand binding and 
the reporter modules could be housed within one protein eventually. The other protein we 
chose was human ubiquitin. We chose ubiquitin as one of our test proteins as well (see 
below). In order to not perturb secondary structural elements of the protein, we 
engineered the tetra-cysteine motif into loops of the proteins. In, DHFR loop 87-92 was 
modified from DVPEIM to CCPECC. Similarly, in ubiquitin loop EVEPSD was 
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modified to CCEPCC (Figure 4.3A, C). The proteins modified to contain the tetra-
cysteine (tetra-cys) motif are now dubbed TC-Ub (for ubiquitin) and TC-DHFR (for 
DHFR) (Figure 4.3A, B). We hypothesize that the position of the tetra-cysteine motif 
precludes the binding of FlAsH (low fluorescence intensity), and that the fluorophore 
only binds upon the unfolding of the protein (high fluorescence intensity), thus reporting 
on the unfolded populations of the proteins. 
 
To test the stability of TC-Ub and TC-DHFR, 5µM protein was incubated with increasing 
concentration of Guanidine hydrochloride (for TC-Ub) and Urea (for TC-DHFR). The 
protein was allowed to incubate for 12 hours at 25 o C. FlAsH was added to a final 
concentration of 0.5µM in the presence of the reductant ethane dithiol (EDT) to 50µM. 
The high concentration of the reductant allowed us to assume equilibrium between free 
FlAsH (conjugated with EDT) and bound FlAsH (bound to protein). The EDT also 
prevents non-specific binding of FlASH to other proteins – a scenario likely to occur 
inside the cell. The protein was allowed to incubate with the dye for 30 minutes prior to 
fluorescence measurements. Fluorescence spectra were collected from 522 to 560 nm 
after excitation at 508 nm. We found that the stability of TC-DHFR was approximately 
2.5 kcal/mol which is a ΔΔG of 3.5 kcal/mol compared to wild type at the same 
temperature (Figure 4.2). Ubiquitin stability was measured to be 4.7 kcal/mol, a value 
which is within the stability range of apo and holo DHFR (Figure 4.3C, D). 
 
Our next objective was to test whether the thermodynamic stability measured by change 
in FlAsH fluorescence is comparable to the stability measured by other methods. This is 
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particularly important for the test protein as any modifications can further perturb its 
stability. We suspected based on previous studies that FlAsH binding does not heavily 
perturb the folding equilibrium (Krishnan and Gierasch, 2008). Also, as the dye is added 
in sub-stoichiometric amounts in the presence of a binding competitor (1,2-ethanedithol 
(EDT)), we assume that FlAsH acts merely as a reporter of the unfolded state. We tested 
this assumption by determining the stability of Ubiquitin in a FlAsH independent manner. 
As ubiquitin has no native tryptophan residues we decided to use circular dichroism to 
determine the stability of our tetra-cysteine ubiquitin construct. These experiments were 
conducted in conjunction with Alexandra Walls, a former undergraduate in the 
laboratory. To test the stability of TC-Ubiquitin, 1.5µM protein was incubated with 
increasing concentration of Urea. The protein was allowed to incubate for 12 hours at 25 
o C. CD signal was collected from 250 to 210 nm and ellipticity at 222 nm was used to 
calculate the stability of TC-Ub.  
 
From our measurements monitoring the change in ellipticity as an output we determined 
the stability of the ubiquitin construct to be 5.3 Kcal/mol. By comparing the stability 
from FlAsh measurements and CD, the two values are comparable and support our 
hypothesis that FlAsH binding does not significantly perturb stability (Figure 4.3E).  
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4.3 Utility of FlAsH binding for stability measurements 
 
A.  Tetra cys DHFR modified at a surface loop (between residues 88-92, see text). 
 
B. Thermodynamic stability of TC-DHFR calculated by measuring increase in FlAsH 
fluorescence as a function of urea concentration. The fluorescence intensity rises with 
increasing urea but drops at 2.5M. Stability calculated to about 2.5 kcal/mol by fitting to 
the two state equation.  
 
C.  TC-Ubiquitin modified at a surface loop (between residues 17-22, see text).  
 
D. Thermodynamic stability of TC-Ubiquitin calculated by measuring increase in FlAsH 
fluorescence as a function of GdnCl concentration. Similar to TC-DHFR fluorescence 
rises with increase in GdnCl, but drops after 4.5 M similar to TC-DHFR. Stability 
estimated to 4.7 kcal/mol.  
 
E. Estimation of TC-Ubiquitin by circular dichroism yields a value of 5.3 kcal/mol 
indicating a mild  perturbation of the stability of TC-Ubiquitin when measured with 
FlAsH fluorescence. 
  
		132 
A. 
 
 
B. 
 
 
 
 
C. 
 
TC-DHFR TC-Ubiquitin
87
88 91
92
17
16
21 20
522 532 542 552
Wavelength (nm)
10
30
20
40
50
60
70
In
te
n
si
ty
 (
c
p
s 
x1
0
4
)
0 2 4
20
30
40
50
10
Urea (M)
In
te
n
si
ty
 a
t 
5
3
5
 n
m
 x
1
0
4
		133 
 
D. 
 
 
 
 
 
 
 
 
 
 
TC-DHFR TC-Ubiquitin
87
88 91
92
17
16
21 20
522 532 542 552
Wavelength (nm)
8
18
28
38
48
58
68
78
88
In
te
n
si
ty
 (
c
p
s 
x1
0
4
)
0 2 4 6
20
40
60
80
0
GdnCl (M)
In
te
n
si
ty
 a
t 
5
3
5
 n
m
 x
1
0
4
Urea (M)
M
R
E
 (
d
e
g
*c
m
2
/d
m
o
le
)
0 2 4 6 8
		134 
E.   
 
 
 
  
522 532 542 552
Wavelength (nm)
8
18
28
38
48
58
68
78
88
In
te
n
si
ty
 (
c
p
s 
x1
0
4
)
0 2 4 6
20
40
60
80
0
GdnCl (M)
In
te
n
si
ty
 a
t 
5
3
5
 n
m
 x
1
0
4
Urea (M)
M
R
E
 (
d
e
g
.c
m
2
/d
m
o
le
)
0 2 4 6 8
3000
2000
1000
		135 
 
 
 
4.3. The choice of test proteins 
One impediment of the MEF construct is the choice of test proteins that can be used. 
There are three major limitations when choosing the test protein for the MEF construct, 
the first being the stability of the test protein. If the stability of the test protein exceeds 
the stability of the ligand bound host protein, there will not be a sufficient energetic 
differential to unfold the test protein. Second is the size of the test protein. A multimeric 
or a large sized protein which physically prohibits the re-union of the split host protein 
will keep the test protein from refolding and binding the ligand, this will not allow the 
MEF system to function as originally designed. The third limitation is the relative 
kinetics of folding and unfolding between the host and test proteins. If the kinetics are 
offset by a large difference, the unfolding of the test protein at the expense of folding the 
host protein may not occur on a measurable timescale regardless of the differential 
between the thermodynamic stabilities (Peng and Li, 2009). 
 
All three of these limitations can be theoretically overcome by either, changing the host 
protein to accommodate a larger stability difference between holo and apo forms of the 
host protein or by varying the size of the host protein to better accommodate the test 
protein. The choice of DHFR manages to address the first limitation somewhat 
successfully as the stability of most proteins (with measured stability) lies between 4 and 
12 kcal/mol which is within the stability range of apo (~0.5 kcal/mol) and holo (TMP 
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bound ~12 kcal/mol by calculation of stability imparted by ligand binding) DHFR. The 
kinetics of folding/unfolding will be intrinsic to the protein of choice and will not be 
dissociable from the protein(s) used for the host and test. For our preliminary work, we 
have chosen to work with two test proteins which are single domain and whose 
thermodynamic stability lies between 0.5 and 12 kcal/mol. Furthermore, the N terminus 
to C terminus distance for these proteins is significantly larger than the point of insertion 
into DHFR, in agreement with the rationale for the MEF construct.  
 
The first choice of test protein was TC-ubiquitin. With the stability of this construct 
known (see section 4.2) and the N to C terminus distance of ~ 37 Å (compared to 6.5 at 
the surface loop of DHFR, see Figure 4.1B), it was a viable candidate for a test protein 
(Vijay-Kumar et al., 1987). Furthermore, with the tetra-cys motif reporting on the 
unfolded state of ubiquitin we now have a readout on how the folding of DHFR impacts 
the folding of ubiquitin by following FlAsH fluorescence. The second test protein we 
used was superfolder GFP (sfGFP), with a reported thermodynamic stability of 9.1 
kcal/mol and an N to C terminus distance of approximately 17 Å (Pedelacq et al., 2006). 
Additionally, this test protein has the intrinsic advantage of being a self reporter as only 
folded superfolder GFP produces fluorescence. Both proteins were cloned into the 
surface loop of DHFR without any flanking linkers into pET16b vectors where the 
expression of these proteins was driven from an IPTG inducible T7 promoter. As a 
schematic we have depicted how the thermodynamic tug-of-war would play out inside 
the cell using the DHFR-TC-Ubiquitin MEF construct. In the first scenario without any 
ligand, a significantly larger fraction of the ubiquitin would be folded compared to 
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DHFR, however, upon titration of the ligand, we would see a shift in these population to 
now favor the folded form of DHFR, thus obligatorily unfolding ubiquitin exposing the 
tetra-cys motif which will be detected by FlAsH fluorescence (Figure 4.4). 
 
 
Figure 4.4 Schematic of the MEF system deployed inside cells 
  
The cartoon shows a schematic of how the DHFR-TC-Ubiquitin MEF system can work 
in vivo. In the first scenario the more stable test protein (TC-Ubiquitin) remains folded in 
the absence of any DHFR stabilizing ligand. This sequesters the FlAsH binding site and 
would show a low level of fluorescence. Upon introduction of the ligand trimethoprim 
(pink), the MEF tug-of-war would now shift such that larger populations of DHFR are 
folded, thus forcing the unfolding of the coupled TC-Ubiquitin exposing the FlAsH 
binding site which would increase the fluorescence signal. 
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4.4. Preliminary results 
In our in vitro experiments with purified DHFR-TC-Ubiquitin (see methods), when the 
DHFR-TC-Ubiqutin construct was titrated with increasing concentrations of 
trimethoprim, 5µM protein was incubated with increasing concentration of trimethoprim. 
The protein was allowed to incubate for 12 hours at 25 o C. FlAsH was added to a final 
concentration of 0.5µM and EDT to 50µM. The protein was allowed to incubate with the 
dye for 30 minutes prior to fluorescence measurements. Fluorescence spectra were 
collected from 522 to 560 nm after excitation at 508 nm. According to our hypothesis, the 
increase in the concentration of the ligand should partition increasing concentrations of 
DHFR to the folded state thereby causing increasing the concentration of unfolded TC-
ubiquitin that will be reported by an increase in FlAsH fluorescence. Indeed, we observed 
an increase in FlAsH fluorescence with increasing TMP concentrations. This supports our 
model that ligand binding drives the equilibrium towards DHFR folding and ubiquitin 
unfolding (see Figure 4.5 A). 
 
For our preliminary in vivo experiment we transformed DHFR-sfGFP into E. coli and 
streaked them onto minimal media plates containing increasing concentrations of 
Trimethoprim. An increase in the TMP concentration should drive the folding of DHFR 
and thus necessarily the unfolding of the coupled GFP. The unfolding of GFP should 
cause a decrease in GFP fluorescence. In good agreement with our MEF model, we 
		140 
observed a loss in fluorescence upon increasing the concentration of TMP. This result 
showed promise to continue our work with the MEF system in vivo where the protein 
folding equilibrium can be tuned by altering the concentration of the ligand (Figure 4.5 
B). 
 
Figure 4.5 In vitro and in vivo demonstrations of MEF constructs  
 
A. MEF system works in vitro. As hypothesized, increasing TMP concentrations causes a 
rise in FlAsH fluorescence indicating the unfolding of TC-Ubiquitin as a consequence of 
DHFR folding. The molar ratio of DHFR-TMP indicates a 1 to 1 binding of the ligand to 
DHFR. As a control experiment, the DHFR-Ubiquitin construct (without any tetra-cys 
motif) does not show any change in fluorescence upon increase in TMP levels thus 
showing the usefulness of the tetra-cys reporter.  
 
B. E. coli cells transformed with DHFR-sfGFP construct were grown overnight on 
minimal media containing increasing concentrations of TMP. Two main observations are 
that the cells are able to grow on large amounts of TMP suggesting that the DHFR 
provides some resistance to the high levels of TMP. Second, the GFP fluorescence is 
reduced at higher TMP concentrations indicating the presence of folded DHFR and thus 
unfolded sfGFP, which is unable to fold and fluoresce. 
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4.5. Pitfalls in the MEF design 
While the MEF system appears to have sound theoretical basis and has been shown to 
work in preliminary experiments, there are certain challenges one has to consider when 
working with this system. First, is the question of what it is that we are measuring? While 
unfolding the test protein as a consequence of folding the host protein can be measured as 
a function of the ligand, it is not truly the test protein that is being tested. The protein 
being tested is now part of the MEF system that is a single chain system and not two 
separate proteins. This introduces a penalty on the thermodynamic stability of the test 
protein inserted into the system. This thermodynamic penalty is further examined by 
Cutler and Lon (Cutler and Loh, 2007) and it is essentially the penalty for physically 
coupling the two proteins exerted on the system. This changes the measured stability of 
the test protein (ΔGtest) to a relative stability (ΔΔGtest) where ΔΔGtest is ΔGtest – ΔGx. In 
this scenario, ΔGtest is the stability of the free test protein when not associated with the 
MEF system and ΔGx is the thermodynamic penalty for insertion of the test protein into 
the MEF system. The major disadvantage of this is that the ΔGx will have to be measured 
for each construct made with the MEF system (due to the inherent differences in stability 
amongst proteins and the varying levels of architectural incompatibilities introduced by 
the varying N to C terminus lengths of the test proteins). Thus, only when the 
measurements are made to obtain ΔGx can we deduce the stability of the test protein, 
otherwise it will only be a relative measurement. This ΔGx can also vary in vivo where 
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environmental factors (see Chapter 1) can influence the folding of the MEF construct. 
However even without the measurement of ΔGx , the strategy would be useful to 
determine the impact of mutations on the stability the test protein relative to wildtype as 
the answer will be a ratio and not true numbers of stability. 
 
Second, mutually exclusive folding constructs are highly aggregation prone in vivo. This 
is not surprising as the design of the construct lends to a large fraction of either the test or 
the host protein being unfolded. In the absence of any degradation, we have found that 
MEF constructs expressed in E. coli are highly aggregation prone. We have seen that the 
presence a TMP solubilizes a large portion of the dDHFR construct from chapter 2. 
However, as we noted in the mathematical derivation (see below), the presence of any 
amount of aggregated protein and the prevention of aggregation is intimately tied to the 
intrinsic ratio of the folding and aggregation rate constants of the protein. Thus any 
aggregation of the construct will not allow us to effectively separate the Kf (folding 
equilibrium constant, a ratio of kf to ku – the folding and unfolding rate constants) and 
kagg, the aggregation rate constant. 
 
Recall from chapter two that the prevention of aggregation by the ligand is dependent on 
the concentration of the ligand to a certain extent and the intrinsic folding vs. aggregation 
propensities of the protein (Equation1). Furthermore, the impact of the ligand at very 
high concentrations is limited by the ratio of the folding equilibrium constant to the 
aggregation rate constant (Equation 2). 
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    (1) 
 
At infinite ligand concentration equation 1 transforms such that  
 
         (2) 
 
One potential solution to this is to purify the protein and exogenously introduce it into the 
cell via a method like electroporation. Although this too does not ensure that the cellular 
environment will not change the status quo of the MEF construct and cause it to 
aggregate inside the cell. A similar issue exists with using the MEF construct in cell 
lysates. 
 
A potential solution to such problems is to design a muturally “inclusive” folding system. 
Such a system has been reported in the joint efforts of the Bardwell – Radford groups 
(Foit et al., 2009). The method they deploy is composed of a β-lactamase fused to the 
protein of interest with sufficiently long linkers such that there is not architectural 
incompatibility and the folding of the two proteins is independent. The system depends 
on periplasmic degradation machinery of E. coli to rapidly degrade marginally stable test 
proteins, and thus the associated β-lactamase . This decrease in β-lactamase levels is then 
reflected in the ability of E. coli (transformed with the β-lactamase construct) to grow on 
β-lactam antibiotics. If mutation in the test protein causes destabilization, that construct 
€ 
f [A] ≅ kagg (ku + ka[L])k f ka[L]+ kagg (ku + ka[L])
=
1
1+ k f ka[L]kagg (ku + ka[L])
€ 
f [A] = 1
1+ k fkagg
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will be more susceptible to degradation and thus will not offer any protection against the 
antibiotic. This system allows for the testing of impact of mutations on the stability of the 
test protein in vivo but does not allow comparison between two entirely different test 
proteins. Another way to approach the problem is by using NMR. Only in the last year 
advances in measuring protein stability inside the cell using NMR have gained traction. 
By either using fluorinated amino acids or by electroporating isotopically labeled protein 
into cells have the effects of the cellular environment been tested on the stability of 
proteins (Danielsson et al., 2015; Smith et al., 2016). Not unsurprisingly, protein stability 
is affected although not drastically depending on the protein and the cellular environment 
surrounding the protein, i.e. stability is context dependent. This is in good agreement with 
the few reports on protein thermodynamic stability inside cells measure in the past 
decade (Ebbinghaus et al., 2010; Guo et al., 2012; Guzman and Gruebele, 2014) 
(Ghaemmaghami and Oas, 2001; Ignatova and Gierasch, 2004). 
 
From Chapter 3 we learned the effect of various chaperones and the degradation enzyme 
lon on the fate of one test protein. Our group has also reported similar effects for several 
other test proteins. These observations highlight the importance of thinking about protein 
folding inside the cell as a kinetic competition for the polypeptide chain. Thermodynamic 
analyses and methods such as the MEF system will allow us to examine the impact of 
mutations on proteins, but this impact will also be manifested in how the protein 
partitions into folded or aggregated states or to the degree it is degraded. Thus an 
approach that considers all potential fates of a protein inside the cell will ultimately yield 
more information about how this process works inside the cell. 
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4.6. Materials and Methods 	
• Cloning, protein expression and purification. 
Cysteine free AS-DHFR was a gift from the Matthews lab (UMass Medical School, 
Worcester MA). The gene was subcloned into the pET16b vector thus getting the protein 
expression under the control of the T7-IPTG system. Insertions into the DHFR sequence 
were performed by the introduction of NdeI and Xho I resctriction enzyme sites into 
DHFR by the standard stratagene quickchange protocol allowing us to ligate desired 
fragments between residues 106 and 107 of the translated protein.  
 
Wildtype DHFR was purified using the following protocol 
• Cell growth and protein induction 
DHFR plasmid (pET 16b) was transformed into E. coli BL21(DE3) cells and a single 
colony was used to start an overnight culture. 1.5% of the overnight culture was used to 
start a fresh 1 L LB + Ampicillin (final 100ug/ml) culture. The 1 L culture was grown to 
OD 600 of 0.6 at which point it was induced with a final IPTG concentration of 1mM for 
4-5 hours. All growth and induction was done at 37 o C. Cells were harvested by 
centrifugation at 4000 x g and resuspended in 20mM HEPES pH7.4 and flash frozen with 
liquid N2 until further use. 
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• Cell lysis: 
Frozen cells were thawed under running cold water until completely thawed and then 
were lysed using the microfluidizer. After being microfluidized, the lysed cells were 
centrifuged at 20,000 rpm for 30 minutes and the insoluble fraction was discarded. The 
soluble fraction was processed further.  
 
• Ammonium Sulphate precipitation 
The first step was to perform an ammonium sulphate precipitation of the protein and or 
contaminants. Solid ammonium sulphate was gradually added to the supernatant after cell 
lysis in 10% increments with slow stirring in 10 minute intervals. At 60% ammonium 
sulphate, the protein (soluble DHFR) was mostly in the supernatant.  
The 60% ammonium sulphate supernatant was resuspended in 20mM HEPES at pH 7.4 
and dialyzed against 20mM HEPES at pH 7.4 to remove as much ammonium Sulphate as 
possible before further treatment. 
 
• DEAE column chromatography 
The dialysate from the ammonium Sulphate precipitation was loaded a pre-equilibrated 
DEAE anion exchange column (pre equilibrated with 20mM HEPES at pH 7.4. The 
protein was loaded on the column and washed with 20mM HEPES at pH 7.4 and eluted 
with a gradient ranging from 20mM to 1000 mM NaCl made in the HEPES. The eluted 
sample was then dialyzed against 20mM Tris pH 7.4 and flash frozen and stored at -80 o 
C till further use.  
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All other DHFR related constructs were purified from inclusion bodies followed by the 
same DEAE column chromatography used for wildtype DHFR. 
 
• Extraction from inclusion bodies 
After cell lysis and centrifugation, the supernatant was discarded and the precipitate was 
washed with 0.1% Triton X-100 containing HEPES buffer at pH 7.4 to remove 
membrane fractions. A second wash step was subsequently performed to remove any 
triton from the first wash. The precipitate was then dissolved in 8 M urea made in 20 mM 
HEPES at pH 7.4 for two hours until most of it dissolved. The unfolded protein from the 
precipitate was then dialyzed against 20 mM HEPES pH 7.4 to remove the urea and 
initiate protein refolding. The dialysate was further purified using the column 
chromatography mentioned above. 
 
• Equilibrium denaturation experiments: 
For the DHFR variants, 3-5 µM protein was added to increasing concentrations of urea 
and allowed to incubate overnight at 25 o C for a minimum of 12 hours. Unfolding of 
DHFR was measured by tryptophan fluorescence after excitation at 295 nm followed by 
acquiring spectra between 320 and 380 nm. Fluorescence intensity at 344 nm was used to 
fit to the two state equation to determine equilibrium thermodynamic stability. 
Similarly, for the tetra cysteine variants, the denaturation was performed using the same 
procedure mentioned above with either increasing concentrations of urea or guanidine 
hydrochloride. FlAsH fluorescence was measured after excitatation at 508 followed by 
acquiring spectra between 520 and 560 nm. Intensity at 535 nm was used to fit to the two 
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state equation to determine stability. Denaturation of TC-Ubiquitin was also followed 
using circular dichroism by measuring the intensity at 222 nm which reports on the alpha 
helical secondary structure. 
 
• MEF experiments in vito and in vivo 
• In vitro 
Purified DHFR-TCUb (5 µM) was incubated with increasing concentrations of TMP and 
allowed to incubate overnight at 25 o C. After a minimum of 10 hours of incubation, 
FlAsH and EDT were added at a final concentration of 0.5 and 50 µM respectively. 
Incubation with the fluorophore was allowed to occur for 30 minutes and FlAsH 
fluorescence was subsequently measured. The same experiment was conducted with 
DHFR-Ub (no tetra cys motif) to ensure that FlAsH fluorescence reports on the unfolding 
of TC-Ubiquitin with high fidelity. 
 
• In vivo 
DHFR-sfGFP constructs were transformed into BL21(DE3) cells and the cells were 
plated on minimal medium containing increasing concentrations of TMP. The plates were 
incubated at 37 o C overnight and were imaged using eh syngene gel documentation 
device. 
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CHAPTER 5 
QUO VADIS 
 
5.1. Summary and conclusions 
The questions which have motivated my research have a shared thread of understanding 
how the in cell environment can alter the protein folding landscape. I have asked two 
specific questions regarding the in vivo environment; the first was the impact of high 
affinity ligands on the folding fate of proteins and the second was the impact of the 
proteostasis network components on the folding fate of an obligatory chaperone 
dependent client protein. To understand protein folding inside the cell and the impact of 
the cellular environment on the protein, we have invoked a generalizable model of kinetic 
partitioning which states that the synthesized polypeptide chain is partitioned between 
correct folding, off-pathway intermediates which lead to aggregation, or degradation. All 
three fates – folded, misfolded (aggregated) and degraded are a result of intrinsic protein 
biophysical properties such as the rate constants governing each reaction. Upon this 
generalizable model of kinetic partitioning we have overlaid either the effect of a high 
affinity ligand – which then allows us to hypothesize the altered fate of the protein in the 
presence of such a ligand or we have overlaid the proteostasis network which similarly 
allows us hypothesize how chaperones and degradation machinery alter the folding fate 
of the protein under consideration.  
 
Using a combination of experiments and mathematical modeling, we were able to arrive 
at several key conclusions regarding the impact of ligands and of the proteostasis 
components on the folding of proteins inside the cell. First, we were able to 
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mathematically deduce that the impact of a ligand was limited by the ratio of the intrinsic 
folding to aggregation and/or degradation rate constants. Our tests using Trimethoprim 
and 1-deoxygalactonojirimycin were able to experimentally determine this limit for a test 
protein (DHFR) and for a protein linked to late onset Fabry disease (α-galactosidase) 
respectively. Furthermore the results of this study also highlighted the importance of 
understanding the kinetic partitioning when it comes to pharmacological chaperone 
therapy along with the thermodynamic effects of the ligand. Finally this study now 
provides a feasible model as to why certain protein mutations – mutations that hamper the 
intrinsic folding of the protein are non-responsive to pharmacological chaperone therapy. 
 
In the case of the impact of the proteostasis network on the folding of an obligatory 
chaperone client, this is to our knowledge the first study, which seeks to address why 
certain proteins have evolved to rely on chaperones to fold, while many others fold 
spontaneously. Initial models from simulation experiments regarding the impact of 
chaperone and degradation components were tested by experimentally varying the levels 
of protein (MetK) and proteostasis components (GroELS, DnaKJE and lon). By varying 
these components we shed light into the intrinsic propensity of our chaperone client to 
aggregate, furthermore, we were also able to show how DnaK can work in collaboration 
with GroEL to increase the pool of folded protein and finally how lon specifically targets 
the misfolded state of MetK and acts to lower the concentration of aggregated protein.  
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5.2. Significance of the findings 
While our experiments and modeling have primarily been in E. coli cells, our results 
especially about ligand binding have far reaching consequences. Importantly, the central 
concept of kinetic partitioning can be used to describe the distribution and equilibria 
governing protein folding and function inside the cell. One notable example of how 
kinetic partitioning can manifest in disease is the case of cystic fibrosis. The CFTR 
channel can be mutated in ways such that either the trafficking through the endoplasmic 
reticulum is altered, or there is impairment of the function of the channel upon reaching 
the membrane or the protein that reaches the membrane is rapidly degraded. All three 
scenarios cause a loss of function for the cell, which is detrimental to health. By suitably 
designing ligands such that either or all of the three pathways is/are targeted, we can now 
hypothesize how the kinetic partitioning of CFTR can be altered to improve cellular 
health. Secondly, several housekeeping and oncogenic proteins interact with cellular 
quality control machinery. These include but are not limited to clathrin, tau, p53, and 
STAT (Kasembeli et al., 2014; Trinidad et al., 2013; Yu et al., 2014). Mutations in these 
proteins often result in gain of toxicity or loss of function diseases. Thus our knowledge 
of how the proteostasis network deals with obligatory clients allows us to ask questions 
about eukaryotic systems as well. For example, how does a p53 mutation affect its 
interaction with the TRiC/CCT (the eukaryotic Hsp60) and how does that lead to disease? 
Similarly such questions can also be asked of organellar proteostasis. 
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5.3. Future directions: 
The pharmacological chaperone work described in chapter 2 for the α-galactosidase 
enzyme was initially pioneered by Amicus therapeutics, the company currently taking the 
drug through phase 3 clinical trials as a small molecule therapy for Fabry disease. It was 
their work with the small molecule that initially showed a rise in enzyme concentration 
and activity upon treating cells expressing several mutant versions of α-galactosidase 
responsible for Fabry disease. This would be a great platform for a collaboration where 
the modeling approach we used in chapter 2 can be used to generate biophysical 
information regarding several Fabry disease causing mutants. The input for these models 
would theoretically be the enzyme activity – a surrogate for folded protein (or as in our 
case, the fraction remaining) and the concentration of DGJ used to achieve those enzyme 
activity levels. This would be a good database describing the folding/degradation 
competition for several versions of a protein inside eukaryotic cells. Much of this 
information can also be found in some of the work published by Amicus (Benjamin et al., 
2009; Wu et al., 2011). For continuing the work to understand how folding/aggregation 
or degradation rate constants affect the impact of the ligand, future studies with known 
DHFR mutants can be pursued using similar experimental approaches. We have not 
characterized the folding or unfolding rate constants of the dDHFR construct used in our 
study, however we can test the ligand approach on other DHFR mutants (such as the one 
described by Cho et al. 2014) to further validate our system. Conversely, an attempt can 
be made to purify sufficient amounts of the mutant α-GAL (R301Q) to characterize its 
folding rate constant. Essentially, the ligand binding system can be further validated by 
either testing the in vitro parameters of different mutants of either of our model proteins 
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and by performing similar in vivo ligand titration experiments on other mutants of these 
proteins. 
 
Our experiments regarding the folding of MetK were performed in E. coli cells using 
plasmids to overexpress the components under investigation. This approach allows 
limited control of the levels of protein expressed and thus limits the amount of collectable 
experimental data that can be fitted by FoldEco. To improve our understanding of the 
impact of the proteostasis system we need a more precise way to control the 
concentration of the components without drastically altering the protein folding reaction 
going on inside the cell. Refolding experiments, where denatured protein is diluted into 
conditions favoring folding will not be appropriate as they will not recapitulate the 
involvement of the ribosome in synthesis and folding. To address this problem, we can 
use an in vitro transcription and translation system, such as the PURE system to 
synthesize the protein of choice while externally supplementing chaperones at the desired 
concentration to determine their impact on folding. One good test protein to follow up on 
would be MetK, as we can further probe how having GroEL influences the folding of this 
protein. Similarly, given the abundance of information we have on CRABP I mutants and 
their folding, we can use those as test proteins to better understand how varying the 
biophysical properties changes chaperone dependence to fold successfully. The in vitro 
nature of this experiment now allows us to examine multiple proteins in a more rigorous 
fashion albeit in in vitro conditions which lack certain cellular complexities – particularly 
molecular crowding and co-solutes. 
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One aspect where FoldEco is limited is in the number of proteins that can be tackled by 
the program. Currently, FoldEco is designed to handle how the flux of one protein varies 
during expression and how that protein relies on proteostasis network components based 
on its intrinsic folding/misfolding parameters. Experimentally, we can start with the 
introduction of two proteins and investigate how the proteostasis network would respond 
to two entities folding simultaneously. Once we learn more about this, we can start 
thinking about how we could express multiple proteins simultaneously and track their 
folding fate inside the cell. These experiments would allow us to expand FoldEco to 
incorporate the folding of multiple proteins inside the cell – which is what routinely 
occurs under physiological conditions. 
 
A further extrapolation of the folding of MetK investigated in chapter 3 is how this work 
can be applied to proteins that heavily depend on the proteostasis machinery. This 
scenario is likely to occur when proteins accrue destabilizing mutations leaving them 
susceptible to aggregation. Previous work by the Hartl lab has shown how aggregation 
prone proteins sequester metastable proteins thus causing a secondary gain of toxicity 
phenotype. Furthermore these aggregates also tend to sequester chaperones that depletes 
the proteostasis machinery leaving the entire proteome vulnerable to misfolding and 
aggregation – or premature degradation, all scenarios detrimental for cellular health 
(Walther et al., 2015) (Olzscha et al., 2011). Using our understanding of how a GroEL 
substrate interacts with the chaperoning machinery inside the cell, we can now design 
mutant versions to rely less or more on the chaperone components and thus alter the 
burden on the proteostasis network. Alternatively, we can use proteins with diverse 
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biophysical parameters with different chaperone dependencies as stressors for the 
chaperone machinery. What this would allow us to do is ask the question, that if the 
chaperones are engaged with the stressor protein, which proteins are left unprotected in 
the proteome. Using quantitative mass spectrometry approaches such as isotopic labeling 
in SILAC experiments or using multiple tandem mass tags, we can determine which 
proteins are aggregation sensitive and to what extent when a stressor protein is introduced 
into the cell. We can then extend this analysis to introduce a disease variant and ask 
similar questions. 
 
Lastly, the concept of kinetic partitioning can be applied to study protein folding in 
eukaryotic systems. One avenue is to pursue the folding of lysozomal proteins and 
systems where pharmacological chaperones are being investigated. However, another 
area of interest would be the endoplasmic reticulum (ER) (Braakman and Hebert, 2013). 
About a third of all proteins synthesized in eukaryotic cells are through the secretory 
pathway (the lysosome also belongs to this general pathway). Furthermore, several 
chaperones in the secretory pathway have been investigated extensively. Analogous to 
the cytosolic version, the chief chaperone in the ER is BiP, which belongs to the Hsp70 
family of chaperones. Additionally, there are other modifications such as the addition of 
carbohydrates – which is also monitored by specific lectin binding chaperones. Finally, 
some proteins are secreted from the cell to the outside of the cell. Thus a simplified 
model, which involves kinetic partitioning, emerges from these factors. This models 
encompasses synthesis, translocation into the ER, binding BiP and the carbohydrate 
chaperones and secretion and the flux of the protein of interest through these points. Thus 
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using particular readouts such as concentrations of chaperones, the concentrations of 
proteins inside and outside the cell one can begin to build an understanding of how 
protein folding works in the ER. 
 
5.4. Experimental Caveats and potential ways to address them 
For chapters two and three, where we study the impact of ligands or chaperones; we use 
fraction aggregated as a readout for how the protein partitions between the folded and 
aggregated state. Though we call our readouts as aggregated or soluble, they are in fact 
placeholders for those properties. Our experimental methods allow for the separation of 
insoluble (which we call fraction aggregate) and soluble (which we call fraction folded) 
species after cell lysis. However, the insoluble and soluble are difficult to obtain cleanly 
and can be comprised of several different species. For example, the soluble fraction can 
be comprised of well-folded proteins, ligand bound proteins, protein molecules bound to 
chaperones, soluble higher order species, and unfolded species. It is difficult to separate 
the contribution of each of these species to the total population of the protein present in 
the soluble state, however two main follow up experiments can be performed to 
determine how the population of soluble protein is distributed. The first would be to 
perform enzyme activity assays. We would assume that only well folded proteins (that 
are enzymes like MetK) would show enzyme activity. This measurement would help 
determine how much of the soluble pool is folded to the native state. The second 
experiment would be to determine how much of the protein is distributed amongst the 
cellular chaperone pool. In order to do this, one would require immunoprecipitation of 
the chaperones and analysis of the contents bound to the chaperone. One has to be 
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cautious during this experiment because the first step would be to deplete the ATP in the 
soluble fraction so that the chaperone bound protein molecules remain trapped in the 
chaperone and second, one has to try to precipitate almost all the chaperone molecules to 
get a clear estimate of the population of proteins that are soluble and chaperone trapped. 
 
Fraction aggregate measurements require the resuspension of proteins left insoluble after 
cell lysis. Several times, the insoluble pellet will not be entirely resuspended by the 
buffer, and the contents will not be homogeneously mixed. This is a potential source of 
error for the measurement of the aggregated species. One way to overcome this is to 
resuspend the insoluble fraction in a solution containing mild detergent or urea. This 
treatment will help dissolve the insoluble species better and thus get a better handle on 
the fraction aggregated. Additionally one can use a proteomic protein perpetually found 
in the insoluble fraction as an internal control to compare across samples. This will serve 
as a reference point for all samples and one can determine if the resuspension procedure 
drastically varied between samples. 
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APPENDIX 
DERIVATION OF LIGAND BINDING AND DATA TABLES FOR CHAPTER 
THREE 	
DERIVATION OF LIGAND BINDING–  provided by Evan Powers 		The	derivation	below	shows	the	detailed	steps	of	the	model	describing	how	the	effect	of	ligand	binding	(described	in	Chapter	2)	can	be	explained	by	the	ratio	of	the	intrinsic	folding	to	aggregation	or	degradation	rate	constants.	This	derivation	was	provided	to	us	by	Evan	Powers.		
The rate equations for this model are: 
![!]!" = 𝜎 − 𝑘! 𝑈 + 𝑘! 𝑁 − 𝑘!"" 𝑈 − 𝑘!"# 𝑈      (1) 
![!]!" = 𝑘! 𝑈 − 𝑘! 𝑁 − 𝑘! 𝑁 𝐿 − 𝑘!"# 𝑁      (2) 
![!]!" = 𝑘!"" 𝑈          (3) 
![!:!]!" = 𝑘! 𝑁 𝐿 − 𝑘!"# 𝑁: 𝐿        (4) 
![!"#]!" = 𝑘!"# 𝑈          (5) 
![!"#]!" = 𝑘!"# 𝑁 + 𝑘!"# 𝑁: 𝐿        (6) 
where the bracketed symbols represent the concentrations of the corresponding states. 
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Case 1: No ligand – and monitoring the fate of the aggregated protein 
When no ligand is present but there is aggregation, degradation, and/or secretion of 
protein, the terminal states are the aggregated, degraded, and secreted states. The amount 
of unfolded and native protein within the compartment in which protein is produced will 
eventually become negligible compared to the amount of protein in terminal states at long 
times. However, the unbound native state will be a substantial fraction of the total protein 
at earlier times. To understand the time-dependence of this system it is useful to break up 
the protein expression time course into two time periods. In the first time period, the 
amount of native protein is relatively small and ku[N] is small as well. As a consequence, 
[U] fairly quickly reaches a “weak” pseudo-steady state in which the unfolding of native 
protein is negligible (the pseudo-steady state is weak in the sense that it evolves to 
another, more robust steady state on the time scale of the experiment). The value of [U] at 
this pseudo-steady state can be determined from equation (1) by setting ku[N] = 0: 
𝑈 !!,! = !!!""!!!"#!!!        (7) 
This value for [U] can be inserted into equations (3) and (5), which can then be solved to 
yield expressions for the rate of accumulation of aggregated and degraded protein during 
the first period: 
𝐴 !,! = !!""!"!!""!!!"#!!!         (8) 
𝐷𝑒𝑔 !,! = !!"#!"!!""!!!"#!!!        (9) 
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The rate of accumulation of native protein inside the compartment depends on the rates of 
folding and secretion and can be obtained by substituting the expression for [U]ss,1 into 
equation (2) and solving the resulting differential equation to yield: 
[𝑁]!,! = !!!!!"!!!!"#!!! !!!!!!"#!!!"#        (10) 
Inserting this expression for [N]t,1 into equation (6) and solving the differential equation 
yields the time dependent concentration of secreted protein: 
[𝑆𝑒𝑐]!,! = !!!!!""!!!"#!!! 𝑡 − !!!!!!"#!!!"#       (11) 
Note that when there is no secretion (ksec→0), equation (10) reduces to 
[𝑁]!,! = !!!"!!""!!!"#!!!         (12) 
In the second time period, [N] will have gotten large enough that unfolding can balance 
folding and a more robust pseudo-steady state is achieved. The concentrations of 
unfolded and native states in this second time period can be determined by setting 
equations (1) and (2) equal to 0 and solving: 
𝑈 !!,! = ! !!!!!"#!!""!!!"# !!"#!!! !!!!!"#       (13) 
𝑁 !!,! = ! !!!!""!!!"# !!"#!!! !!!!!"#       (14) 
The rates of accumulation in the terminal states can be obtained by inserting these values 
for [U]ss,2 and [N]ss,2 into equations (3), (5), and (6) and solving to give: 
𝐴 !,! = ! !!!!!"# !!""!!!""!!!"# !!"#!!! !!!!!"#       (15) 
		163 
𝐷𝑒𝑔 !,! = ! !!!!!"# !!"#!!!""!!!"# !!"#!!! !!!!!"#      (16) 
𝑆𝑒𝑐 !,! = ! !!!!"!!!!""!!!"# !!"#!!! !!!!!"#      (17) 
The crossing over (temporally) from the first to the second time period happens gradually 
and continuously. But one way to estimate the cross-over time is to set the right-hand 
sides of equations (10) and (14) equal to each other and solve for t (time), which yields 
𝑡! = !" !! !!""!!!"#!!! !!"#!!""!!!"# !!!!"# = !" !!!!"#!! ! !!"#!!!!""!!!"# !!!!"# = !" !!!!"# !!!! !!!!""!!!"#!!"#  (18) 
where Kf = kf/ku is the equilibrium constant for folding and tc is the cross-over time. So 
the time it takes to reach the second period depends on either 1/ku or on Kf/(kagg+kdeg), 
whichever is larger. It also depends on ksec, but in a more subtle way because ksec appears 
in both the numerator and the denominator. If ksec is large (secretion is fast), then tc will 
be small, but if ksec is small or approaches 0—reflecting situations in which secretion is 
slow or doesn’t happen at all—then tc will approach 
𝑡! = !!! + !!!! !!""!!!"# = !!! + !!!!""!!!"#      (19) 
 
Case 2: Irreversible ligand binding with ligand present at a constant concentration 	
When the volume of cells is small relative to the volume of the media, the media will 
serve as a large reservoir of ligand for the cells. The free (unbound) ligand concentration 
will then be effectively constant inside the cells (note that the concentration of ligand in 
the cells and in the media may not be the same, but they should be proportional; that is, 
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an n-fold increase in the ligand concentration in the media should result in an n-fold 
increase inside the cells). Under these conditions, and if [L] >> Kd of the complex, 
natively folded protein should bind effectively and irreversibly to the ligand so that [N:L] 
accumulates while [N] quickly reaches steady state. Of course, this “steady state” is again 
not a system-wide steady state because the concentrations of some species are changing, 
so as before we will refer to it as a pseudo-steady state.  
The pseudo-steady state concentrations of U and N are: 
𝑈 !! = ! !!!!! ! !!!"#!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]      (20) 
𝑁 !! = ! !!!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]      (21) 
Inserting these expressions for [U] and [N] into equations (3) and (5) gives the following 
for the pseudo-steady state rate equations for [A] and [Pdeg]: 
![!]!" !! = 𝑘!"" ! !!"#!!!!!![!]!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]     (22) 
![!!"]!" !! = 𝑘!"# ! !!"#!!!!!![!]!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]     (23) 
Solving these differential equations gives the following for the time-dependent 
concentrations of A and Pdeg: 
[𝐴]! = !!!"" !!"#!!!!!![!] !!!""!!!"# !!"#!!!!!![!] !!! !!" !!![!]      (24) 
[𝐷𝑒𝑔]! = !!!"# !!"#!!!!!![!] !!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]      (25) 
Inserting the expression for [N]ss into equation (S4) and solving gives the time-dependent 
concentration of N:L: 
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[𝑁: 𝐿]! = 𝑘! 𝐿 𝑁!! !!!!!"#!!!"# = !!! !  !!!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!] !!!!!!"# !!"# (26) 
When there is no secretion (ksec = 0), this becomes 
[𝑁: 𝐿]! = !!![!]!!!!!""!!!"# !!!!![!] !!!!![!]      (27) 
Finally, inserting the expression for [N:L]t from equation (26) into equation (6) and 
solving gives the time-dependent concentration of Psec: 
𝑆𝑒𝑐 ! = ! !!!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!] 𝑘!"# + 𝑘![𝐿] 𝑡 − 𝑘![𝐿] !!!!!!"#!!!"#
 (28) 
When ksect >> 1, [Psec]t approaches 
𝑆𝑒𝑐 ! = ! !!!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!] 𝑘!"# + 𝑘![𝐿] 𝑡 − !![!]!!"#  (29) 
 
An observable for in vivo protein expression experiments.  
 
Perhaps the most general and easily measured observable for in vivo protein folding in 
the presence of a fast- and tight-binding ligand is the fraction of the total synthesized 
protein that is neither aggregated nor degraded at a given time point. A general 
expression for this quantity, which we shall denote Fr (for “fraction remaining”) is: 
𝐹! = 1− [!]!![!"#]![!"#]!          (30) 
[Tot]t is simply equal to the protein expression rate multiplied by the time: [Tot]t = σt. 
Inserting this and equations (24) and (25) into this equation yields 
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𝐹! = 1− !!!"" !!"#!!!!!![!] !!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!] ! !!!"# !!"#!!!!!![!] !!!""!!!"# !!"#!!!!!![!] !!! !!"#!!![!]!"  (31) 
This can be simplified to 
𝐹! = 1− !!! !!!!""!!!"# !!! !!!"#!! !!! !!!
= 1− !!!!! !!! !!!!!![!]     (32) 
where B1 = kf/(kagg + kdeg), B2 = ksec/ku, and B3 = ka/ku. At very high ligand concentrations, 
Fr approaches 
𝐹!,[!]→! = 1− !!!!! = 1− !!! !!!!""!!!"#       (33) 
In the absence of ligand and at times such that t > tc (where tc is defined in equations 
(S18) and (S19)), Fr is given by 
𝐹! !!!! ! !! = 1− !"" !!,!! !"# !!,!! !"" !!!!,!! !"# !!!!,!!!"! !     (34) 
Inserting equations (8), (9), (15), and (16) into equation (34) and then collecting terms 
gives  
𝐹! !!!! ! !! = 1− !!""!!!"# !!!!!""!!!"#!!! ! ! !!""!!!"# !!!!!"# !!!!!!""!!!"# !!!!!"# !!!!!"#!"    (35) 
Equation (34) can be simplified and rearranged to give: 
𝐹! !!!! ! !! = 1− !!! !!!!""!!!"# !!"#!!!!!"# + !!! !!! !!!!""!!!"# !!"#!!!!!"# − !!! !!! !!!!!"#
 (36) 
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The quantity in parenthesis has to be positive (because ksec/(ku+ksec) < 1), but the third 
term has to be less than the second term (because it has been stipulated that tc/t < 1), so Fr 
< 1. Furthermore, Fr diminishes monotonically with time until, at very long times where 
tc/t is very small, the third term can be dropped and Fr approaches the time independent 
value: 
𝐹! !! !→! ! !! = 1− !!! !!!!""!!!"# !!"#!!!!!"#       (37) 
In terms of the constants B1, B2 and B3, equations (35) and (36) can be written as follows: 
𝐹! !!!! ! !! = 1− !!!!! !!!!!! + !!! !!!!! !!!!!! − !!!!!     (38) 
Substituting B1 into the expression for tc in equation (19) and then using the result as a 
rough approximation for tc finally gives: 
𝐹! !!!! ! !! = 1− !!!!! !!!!!! + !!!! !!!!!!!! !!!!!! − 1         (39) 
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Table A.1 Chaperone concentrations upon induction 
 
The above table shows the concentrations of chaperones achieved during each run of the 
titration experiments in chapter 3 with the designated concentration of arabinose. The 
concentration listed shows the concentration of the active form of the chaperone, 
tetradecameric for GroEL, hexameric for lon and monomeric for DnaK. 
 
0 67.1 62.5 85.1 
0.002 138 204.3 195.2 
0.02 513.9 482.7 434.6 
0.2 751.4 626 593.8 
0 109.1 128.8 164.9 
0.005 619.2 904.8 1348.5 
0.02 739.4 1438.9 1603.8 
0.2 1485.5 1531.2 1603.8 
0 0 0 0 
0.002 3.4 3.5 3 
0.02 14.4 18.7 20.1 
0.2 27.4 23.1 18.8 
[Arabinose] %w/v
[Arabinose] %w/v
[Arabinose] %w/v
[Lon] +M
Trial 1
Trial 1
Trial 1
Trial 2
Trial 2
Trial 2
Trial 3
Trial 3
Trial 3
[GroEL] +M
[DnaK] +M
		169 
 
 
 
Table A.2 Concentrations and Fagg for MetK synthesized at varying IPTG 
concentrations 
 
The above table shows the concentration of MetK (monomeric) achieved under basal 
conditions of proteostasis at the designated concentration of IPTG and the fraction of 
MetK which aggregates at each concentration of MetK synthesized. 
 
 
1 174.8 157.3 192.3 0.232 0.333 0.2 
5 229 277.9 437.1 0.297 0.147 0.297 
10 592.7 715 968.5 0.312 0.196 0.344 
50 1139.9 1354.9 1777.9 0.38 0.304 0.423 
200 1695.8 1875.9 2115.4 0.468 0.348 0.477 
[IPTG] +M
[MetK] +M Fagg
Trial 1 Trial 1Trial 2 Trial 2Trial 3 Trial 3
Average [GroEL]  134 +M
Average [DnaK]  71 +M
Average [Lon]  0 +M
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Table A.3 Concentrations and Fagg for MetK synthesized at varying IPTG 
concentrations at varying DnaKJE concentrations 
 
The above table shows the concentration of MetK synthesized in the DnaKJE titration 
experiments. The average DnaK concentration is the left most column and the 
concentration of MetK synthesized (at the designated concentration of IPTG) and the 
fraction aggregated for each experiment is listed. 
 
[IPTG] +M
[IPTG] +M
[IPTG] +M
[MetK] +M
[MetK] +M
[MetK] +M Fagg
Fagg
Fagg
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
[DnaK] +M
[DnaK] +M
[DnaK] +M
1 139.7 216.1 187 0.185 0.262 0.268 
5 245.1 209 297.5 0.217 0.3604 0.196 
179 10 658.3 523 577.4 0.251 0.263 0.301 
50 1161.4 1380.5 1811.6 0.441 0.3 0.333 
200 1754.2 1940.5 2188.2 0.401 0.392 0.419 
1 204.6 158.4 138.8 0.027 0.249 0.196 
5 290 187.8 300 0.223 0.297 0.204 
477 10 436.6 500.3 550 0.201 0.238 0.352 
50 1186.7 1410.5 1851 0.209 0.216 0.242 
200 1800.3 1991.5 2245.7 0.243 0.74 0.513 
1 122.2 192.5 237.6 0.127 0.048 0.118 
5 204.8 189.6 332 0.2 0.197 0.172 
657 10 315.4 438.5 555 0.09 0.109 0.202 
50 1119.2 1330.3 1745.8 0.107 0.12 0.165 
200 2091 1854.2 1676.2 0.472 0.26 0.229 
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Table A.4 Concentrations and Fagg for MetK synthesized at varying IPTG 
concentrations at varying GroELS concentrations 
 
The above table shows the concentration of MetK synthesized in the GroELS titration 
experiments. The average GroEL concentration is the left most column and the 
concentration of MetK synthesized (at the designated concentration of IPTG) and the 
fraction aggregated for each experiment is listed. 
 
 
 
[IPTG] +M
[IPTG] +M
[IPTG] +M
[MetK] +M
[MetK] +M
[MetK] +M Fagg
Fagg
Fagg
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
[GroEL] +M
[GroEL] +M
[GroEL] +M
1 192 136 212 0.072 0.353 0.104 
5 310.7 302.7 354.3 0.087 0.088 0.404 
957 10 1199.4 896.5 1395.5 0.188 0.038 0.195 
50 1148.3 1364.9 1791.1 0.122 0.027 0.155 
200 2238.4 1984.9 1794.4 0.26 0.215 0.24 
1 128.9 110.8 173.4 0.281 0.359 0.216 
5 338.8 306.4 368.2 0.047 0.038 0.05 
1260 10 1099.8 843.5 1145.9 0.032 0.102 0.183 
50 1159.2 1378 1808.2 0.179 0.042 0.102 
200 1810.7 2003 2258.8 0.343 0.245 0.154 
1 67.4 46 46.5 0.136 0.143 0.257 
5 83.9 72 77 0.428 0.302 0.222 
1540 10 315.8 354.7 301.8 0.198 0.174 0.124 
50 1152.9 1370.4 1798.3 0.291 0.13 0.272 
200 1635.2 1808.8 2039.7 0.117 0.175 0.143 
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Table A.5 Concentrations and Fagg for MetK synthesized at varying IPTG 
concentrations at varying Lon concentrations 
 
The above table shows the concentration of MetK synthesized in the Lon titration 
experiments. The average Lon concentration is the left most column and the 
concentration of MetK synthesized (at the designated concentration of IPTG) and the 
fraction aggregated for each experiment is listed. 
 
 
 
 
 
1 344.2 263.5 390.4 0.26 0.344 0.338 
5 390.4 355.8 401.9 0.278 0.397 0.315 
3.3 10 536.5 413.5 559.6 0.35 0.414 0.448 
50 982.6 888.6 817.1 0.373 0.386 0.332 
200 1811.5 1696.1 1719.2 0.556 0.494 0.464 
[IPTG] +M
[IPTG] +M
[IPTG] +M
[MetK] +M
[MetK] +M
[MetK] +M Fagg
Fagg
Fagg
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3
1 263.5 240.4 251.9 0.14 0.047 0.192 
5 150 213.5 159.6 0.21 0.129 0.153 
17.7 10 228.9 263.5 217.3 0.261 0.345 0.116 
50 612.9 511.4 494.3 0.196 0.318 0.119 
200 1282.7 1215.4 951.9 0.25 0.291 0.38 
1 138.5 171.1 140.4 0.116 0.106 0.116 
5 171.1 205.8 152 0.119 0.158 0.206 
23 10 182.7 228.9 182.7 0.12 0.13 0.179 
50 698.6 630 592.9 0.202 0.192 0.141 
200 1053.8 882.7 905.8 0.211 0.247 0.103 
[Lon] +M
[Lon] +M
[Lon] +M
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